Shareholder Proposals, Director Nominations and Other Business for the 2022 Annual General Meeting
Notice of Director nominees must include the information required under Linde’s Constitution and must be received by the Company’s Corporate Secretary at its principal executive offices no earlier than the close of business on November 29, 2021 and no later than the close of business on December 29, 2021, unless the date of the 2022 Annual General Meeting of shareholders has been scheduled to be held more than 30 calendar days from the anniversary of the distribution date of this proxy statement. In that case, such notice must be received by Linde’s Corporate Secretary no earlier than the close of business on the 180th calendar day before the date of the 2022 Annual General Meeting of shareholders and no later than the close of business on the later of (i) the 150th calendar day before the date of the 2022 Annual General Meeting of shareholders and (ii) the 10th calendar day following the date on which public announcement of the date of the 2022 Annual General Meeting of shareholders is first made.
Shareholder proposals, director nominations or related written notices must be delivered to the Corporate Secretary, Linde plc, The Priestley Centre, 10 Priestley Road, Surrey Research Park, Guilford, Surrey, GU27XY, United Kingdom.
Shareholders of record at close of business on April 28, 2021 should have received either (1) a notice that Linde’s 2020 Form 10-K and Annual Report to Shareholders and 2020 IFRS Annual Report are available on the internet or (2) a printed copy of this Proxy Statement and the 2020 Form 10-K and Annual Report to Shareholders. If you have received a printed copy of this Proxy Statement without the 2020 Form 10-K and Annual Report to Shareholders, please contact Investor Relations at the address below and a copy will be sent to you.
A copy of Linde’s Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2020 is available to each holder or beneficial owner of Linde’s ordinary shares as of April 28, 2021. This report will be furnished without charge upon written request to the Investor Relations Department, Linde plc, The Priestley Centre, 10 Priestley Road, Surrey Research Park, Guilford, Surrey GU2 7XY United Kingdom. You may also call 001-203-837-2210 or 49-89-35757-1332.
The entire cost of soliciting proxies will be borne by Linde including the expense of preparing, printing and mailing this Proxy Statement. Solicitation costs include payments to brokerage firms and others for forwarding solicitation materials to beneficial owners of Linde’s stock and reimbursement of out-of-pocket costs incurred for any follow up mailings. Linde also has engaged Morrow Sodali LLC to assist in the solicitation of proxies from shareholders at a fee of $8,000 plus reimbursement of out-of-pocket expenses. In addition to use of the mail, proxies may be solicited personally or by telephone by employees of Linde without additional compensation, as well as by employees of Morrow Sodali LLC.
This Remuneration Policy will first address our remuneration philosophy for executive directors, followed by our remuneration philosophy for non-executive directors. As used in this Remuneration Policy: (i) “executive director” means a member of Company’s Board who is also an employee of the Company or any of its subsidiaries and affiliates, and (2) a non-executive director means a member of Company’s Board who not also an employee of the Company or any of its subsidiaries and affiliates. At the time of adopting this policy, the Company’s Chief Executive Officer is the only executive director.
The Company’s executive directors do not receive any separate compensation for their service on the Board in any capacity. Rather, the compensation of the Company’s executive directors, as officers or employees of the Company, is determined by the Board’s Compensation Committee as part of its determination of executive compensation generally. Therefore, the amount and structure of executive compensation is separate from, and fundamentally different than, non-executive director compensation which is determined by the Board’s Nomination and Governance Committee. As such, the policy provisions reflect these different compensation structures and determinations.
The Compensation Committee designs the executive compensation program in order to attract and retain executives, motivate them to achieve strong business results, build a performance-driven culture and to encourage them to earn and own Company stock so that their interests are aligned with those of the Company’s shareholders. The Compensation Committee seeks to achieve these executive compensation objectives by aligning the design of the Company’s executive compensation program with the Company’s business objectives, ensuring a balance between financial and strategic non-financial goals. Fixed compensation in the form of salary is the smallest proportion of compensation. Variable compensation and equity rewards together are the largest proportion of compensation and both of these components are ‘at risk’, meaning these components only have value to the extent the Company performs well. The material components of the executive compensation program in which the CEO’s compensation is determined are set forth below.
Linde plc | Appendix 1-5
Appendix 1: Linde plc Directors’ Remuneration Policy
|
|
|
|
|
|
|
|
Component
|
Operation
|
Opportunity
|
Performance Measures
|
Compensation Deferral
|
Executive directors employed as U.S. employees may elect to defer receipt of all or some portion of their annual variable compensation payments and/or base salaries, subject to limitations to ensure that sufficient un-deferred pay remains available to cover applicable withholding taxes and benefit premiums.
|
Deferrals are unfunded and unsecure. The executive director’s right to receive future payment of deferred compensation is no greater than that of a general creditor of the Company. Prior to payment, participants may invest their deferred compensation into either:
(1) the Linde plc stock-unit equivalent account whose value tracks the market value of Linde’s stock, including reinvestment of dividends into additional Linde stock-equivalent units, or
(2) a fixed income account whose interest rate is fixed annually and is equal to the 1-year U.S. Treasury Bond rate as of the end of the immediately preceding year, plus 50 basis points.
|
Not applicable
|
Long Term Incentive Equity Awards
Long term incentives are an essential component of Linde’s overall compensation plan for employees and executive directors. Equity awards align employee and shareholder interests through share ownership, motivating executives to achieve business objectives established to promote the Company’s long term growth, profitability and success. Equity awards are also critical to attracting and retaining leaders who are vital to the Company’s sustained financial success.
Equity awards are a substantial portion of each executive director’s aggregate target compensation. This contributes to ensuring a strong alignment of executive directors’ and shareholders’ long-term interests. Annual grants of equity awards are made to incent and reward sustained performance.
Various types of equity awards may be granted under the Company’s long-term incentive plans that may be in effect from time to time. However, equity awards are typically granted as a mix of stock options, performance share units (PSUs) and restricted stock units (RSUs). The mix and type of equity awards granted to the executive directors is typically the same as those granted to all eligible executives of the Company. Fully aligning the leadership team, from mid-management to officers, helps sustain the
Linde plc | Appendix 1-6
Appendix 1: Linde plc Directors’ Remuneration Policy
Company’s pay for performance culture by incenting and rewarding all participants with the same goals and performance results.
Except upon a change- in-control (as defined in an applicable plan) and in certain other limited situations, including the participant’s death or disability, the following outlines in general terms the material terms of equity awards that are typically granted to executive directors:
Type*
|
Time Vesting
|
Performance Vesting
|
Stock Options / Stock Appreciation Rights (“SARs”)
|
May partial vest after 1 year; minimum 3 years full vesting; 10 year maximum term
|
Achievement of performance goals may be included in order for the Stock Options or SARs to vest, with a minimum 1 year performance period; however, performance goals are not required for vesting. 10 year term maximum
|
Restricted Stock &
Restricted Stock Units (“RSUs”)
|
May vest in not less than 3 years, with pro rata vesting over 3 year period permitted.
|
Achievement of set performance goals may be included in order for the Restricted Stock or RSUs to vest, with a minimum 1 year performance period; however, unless included, performance goals are not required for vesting.
|
Performance Share Units (“PSUs”)
|
PSUs include a performance period during which performance goals must be achieved in order for vesting to occur.
|
Achievement of set performance goals must occur in order for the PSUs to vest, and such vesting will occur at, above or below target in accordance with the achievement of the set performance goals. Minimum 1 year performance period.
|
Stock Ownership and Anti-Hedging Policy
In order to align executive directors’ interests with shareholder interests, the Compensation Committee has established a stock ownership policy which applies to executive directors. Under the Company’s Stock Ownership Policy, stock ownership as a multiple of base salary must be met, and unless the stock ownership level is met, an executive director may not sell any of his or her holdings of Company stock and must hold all shares acquired after tax upon vesting of PSUs, RSUs or other equity awards and shares acquired upon an option exercise net of shares used to pay taxes and/or the option exercise price. An executive officer may not engage in hedging transactions related to Company stock that would have the effect of reducing or eliminating the economic risk of holding Company stock. In addition, no executive officer may pledge or otherwise encumber any of his or her Company stock.
Recapture Clawback Policy
The Board of Directors of the Company has adopted a policy for the recapture of annual performance-based variable compensation payouts, equity grants and certain equity gains in the event of a later restatement of financial results. Specifically, if the Board, or an appropriate committee thereof, has determined that any fraud by any executive director of the Company materially contributed to the Company
Linde plc | Appendix 1-7
Appendix 1: Linde plc Directors’ Remuneration Policy
having to restate all or a portion of its financial statements, the Board or committee shall take, in its discretion, such action as it deems necessary to remedy the misconduct.
In determining what remedies to pursue, the Board or committee will take into account all relevant factors, including consideration of fairness and equity. Among those remedies, to the extent permitted by applicable law and not withstanding anything to the contrary in any Company equity or other compensation plan, award agreement or contract, the Board or its committee may require cancellation, forfeiture or reimbursement of any performance-based cash, stock or equity-based award paid or granted to, or gains realized by (such as through the exercise of stock options, payment or settlement of awards or sale of equity securities), by, any executive director of the Company, if and to the extent that:
•
|
the amount of such cash, stock or equity-based award was calculated based upon, or realized gain can reasonably be attributed to, certain financial results that were subsequently reduced due to a restatement, and
|
•
|
the amount of the cash, stock or equity-based award, or gain that would have been paid or granted or realized, would have been lower than the amount actually paid or granted or realized.
|
Severance Benefits
Generally, the Company makes available to executive directors severance benefits that are similar to those provided to other employees based upon the location of their employer. In some cases, an executive director’s severance entitlements may be provided pursuant to an individual employment or severance agreement between the executive director and the Company or its affiliate. For example, for U.S. based executive directors, the following terms will apply:
•
|
No severance pay-out and a forfeiture of unvested equity are required upon a for-cause termination.
|
•
|
Upon a without-cause termination, maximum payment is generally limited to 26 weeks of base pay, calculated based upon length of service and salary rate at time of termination.
|
•
|
The Company retains discretion to pay additional severance in limited cases.
|
Contract of employment
At the date adoption of this policy, no executive director has a contract of employment with the Company or is subject to any notice period.
NON- EXECUTIVE DIRECTOR COMPENSATION
Each director serves for a one-year term concluding at the later of (i) the annual general meeting of shareholders after such director was last appointed or reappointed, and (ii) until his successor is elected and qualified.
The compensation paid to non-executive directors is determined by the Board of Directors from time-to-time, and includes a portion of cash compensation and an element of equity-based compensation, designed to provide greater alignment of interests between non-executive directors and the Company's shareholders. This equity-based compensation is not subject to the achievement of performance metrics given the nature of the role performed by the non-executive directors. Executive directors do not receive any separate compensation for their service on the Board.
Cash Compensation
Cash compensation is determined by the Nomination & Governance Committee and ordinarily comprises a majority of compensation. At the date of adoption of this Remuneration Policy, cash compensation is set at 60% of the entire annual Board compensation, as follows:
•
|
an annual retainer paid quarterly to the Chairman of the Board.
|
•
|
an annual retainer paid quarterly to all other directors.
|
•
|
an additional annual retainer paid quarterly to the Chairman of the Audit Committee.
|
•
|
an additional annual retainer paid quarterly to each chairman of the Compensation Committee and the Nomination and Governance Committee.
|
Linde plc | Appendix 1-8
Appendix 1: Linde plc Directors’ Remuneration Policy
Retainers will be prorated to reflect actual service for directors joining the Board or terminating Board service during any given quarter.
Equity Compensation
In addition to the cash compensation set forth above, each non-executive Director receives an annual equity stock compensation grant at a level determined annually by the Nomination & Governance Committee, which, at the date of adoption of this Renumeration Policy is set at 40% of the value of the entire annual Board compensation.
The equity stock compensation grants are in the form of restricted stock units that will fully vest and will be non-forfeitable after one-year from the date of grant, but a prorated portion will be paid out if a director’s service on the Board terminates before the one year anniversary of the grant unless the director is removed by the shareholders or is removed for cause, in which case the grant will be forfeited. Restricted stock units will be paid out as soon as practicable after the vesting in Linde plc ordinary shares on a one-for-one basis.
Stock Ownership and Anti-Hedging Policy
In order to align directors’ interests with shareholder interests, the Board has established a stock ownership policy which applies to non-executive directors. Under this Stock Ownership Policy, each non-executive director must acquire and hold Company stock equal in value to at least five times the base annual compensation retainer awarded in the form of equity awards. Non-executive directors have five years from their initial election to the Board to meet this requirement. Unless the stock ownership level is met, a non-executive director may not sell any of his or her holdings of Company stock and must hold all shares acquired after tax upon vesting of RSUs net of shares used to pay taxes. A non- executive director may not engage in hedging transactions related to Company stock that would have the effect of reducing or eliminating the economic risk of holding Company stock. In addition, a non-executive director may not pledge or otherwise encumber any of his or her Company stock.
Preparation of the Remuneration Policy
The Compensation Committee and the Nomination and Governance Committee receive independent advice from each of their compensation consultants, which also provide the Compensation Committee and the Nomination and Governance Committee with independently sourced data to assist the committees in setting the Remuneration Policy. The Chief Executive Officer does not attend meetings of the Compensation Committee unless expressly invited to do so by the Chair of the Compensation Committee. The Compensation Committee was mindful of managing any conflicts of interest in preparing this Remuneration Policy during the process and no individual was involved in determining his/her own arrangements.
The Board reserves the discretion to increase or decrease total compensation in appropriate circumstances such as where: the nature or scope of a director’s role or responsibilities changes or in order to be competitive at the median level of peer companies; the compensation is not deemed to reflect appropriately the individual’s contribution or the overall business performance; or the compensation does not appropriately take into account the scope of responsibilities attendant with service on the board of a public limited company that is incorporated under the laws of Ireland and whose stock is listed on the New York Stock Exchange and the Frankfurt Stock Exchange and therefore subject to dual public company regulation in the U.S. and the European Union. Any discretionary adjustments will be detailed in the following year’s annual report on compensation.
Linde Employees
The Compensation Committee considers the general basic salary, compensation arrangements and employment conditions for the broader employee population when determining the remuneration policy for executive directors.
Linde plc | Appendix 1-9
Appendix 1: Linde plc Directors’ Remuneration Policy
Shareholder Views
The Board values shareholders’ input on the design of the Company’s compensation programs. The Company has a robust shareholder outreach program that allows the Board and management to remain responsive to shareholder concerns and opinions, including on compensation matters. The outreach program includes ongoing interaction between the Investor Relations group and investors, and an annual investor outreach effort.
The Board believes that these programs are structured to deliver realised pay that is commensurate with performance and that they reflect a pay for performance approach to executive director pay that holds management accountable for producing profitable growth. Based upon the Board’s views on the current approach to director compensation, the Board has not made any significant structural or philosophical changes to our policy as a result of any comments or feedback expressed by shareholders on any aspects of compensation.
References in this Remuneration Policy to the Board include the Board as well as any other relevant committees of the Board.
Linde plc | Appendix 1-10
Appendix 2: Linde plc Directors’ Remuneration Report
Appendix 2: Linde plc Directors’ Remuneration Report
DIRECTORS' REMUNERATION REPORT FOR LINDE PLC
The company is subject to disclosure regimes in the United States, Germany and Ireland. While some of the disclosure requirements in these jurisdictions overlap or are otherwise similar, some differ and require distinct disclosures. As a result, you will find our Irish Statutory Directors' Remuneration Report (the "Remuneration Report") within this section of the Annual Report. The company paid the directors in accordance with the remuneration policy on which the company's shareholders will be asked to vote, on an advisory and non-binding basis, at the 2021 Annual General Meeting of Shareholders.
Introduction
Linde's Board of Directors (the “Board”) believes that our current program is competitive and appropriate within the market where we primarily compete for directors and executive talent. We are sensitive to the compensation governance practices prevalent in our peer group.
2020 compensation highlights
The company continued to deliver strong financial results and significant shareholder value in 2020 despite the macroeconomic impact of the COVID-19 pandemic. Through continued cost and price actions coupled with high reliability, Linde realized 12% growth in EPS and 21% growth in operating cash flow. Furthermore, the company announced new sustainability goals, including the reduction of greenhouse gas emissions intensity of 35% by 2028. In a year dominated by COVID-19, Linde’s medical gases and homecare services played a critical role in the battle against this pandemic. Additionally, the company increased its dividend for the 27th consecutive year in 2020, by 10%, and repurchased $2.4 billion of shares.
As a result of the Company’s strong performance, the annual variable compensation program’s 2020 Corporate payout factor was 127.3% of target. No adjustments were made during the year to the original 2020 variable compensation financial goals that were established by the Compensation Committee in February 2020. Additionally, the CEO did not receive a base salary increase in 2020 due to the Company’s decision to forego salary increases in response to the pandemic’s impact on the macroeconomic environment.
How Compensation Decisions are Made
Shareholder Engagement
The company maintains a robust outreach program whereby management regularly discusses executive compensation design and other relevant matters with shareholders. When making compensation program decisions, the Compensation Committee considered shareholder feedback received during outreach sessions.
Role of the Compensation Consultant
The Compensation Committee engages a third-party compensation consultant to assist in analysis to inform and support the Compensation Committee’s decisions on executive compensation. For its consideration of 2020 executive compensation, the Compensation Committee engaged Deloitte Consulting LLP (“Deloitte Consulting”). Subsequently, effective 1 September 2020, the Committee engaged Pearl Meyer LLC (“Pearl Meyer”) as its new compensation consultant following the termination of its contract with Deloitte Consulting.
Before engaging Pearl Meyer, and as part of the Committee’s standard practice to conduct such a review prior to selecting a new consultant and once annually thereafter, the Committee assessed the independence of the compensation consultant. After considering the six independence factors specified in the NYSE listing standards, the Committee determined that Pearl Meyer met the criteria for independence.
The scope of Pearl Meyer’s engagement includes:
|
a.
|
Review of compensation programs and preparation and presentation to the Compensation Committee of reports on executive compensation trends and other various materials
|
|
b.
|
Review of the peer group analysis and compensation benchmarking studies prepared by management and review of other independent compensation data
|
Linde plc | Appendix 2-1
Appendix 2: Linde plc Directors’ Remuneration Report
|
c.
|
Input on the CEO’s compensation
|
|
d.
|
Review of and advice on compensation program design proposals presented by management for the Compensation Committee’s consideration.
|
Compensation Peer Group
The Compensation Committee established a Compensation Peer Group to be used to assess competitive market compensation ranges for its top officers. Elements considered by the Committee when choosing companies for peers included market capitalization, revenue, net income, industry, global operations, location of headquarters and stock markets where publicly traded. The Committee intends to review the peer group on an annual basis, though will only make changes when appropriate as it values year-over-year consistency going forward. Below are the companies comprising the Compensation Peer Group that was used for making pay decisions for calendar year 2020.
Compensation Peer Group
|
3M
|
Gilead Sciences
|
Merck & Co.
|
Abbvie
|
Halliburton Company
|
Mondelez Intl
|
Abbott
|
Honeywell Intl
|
PPG Industries
|
Caterpillar
|
InBev
|
Raytheon
|
Coca-Cola
|
Johnson Controls
|
Roche
|
Cummins
|
Kraft Heinz
|
SAP
|
Danaher
|
LyondellBasell
|
Sherwin-Williams
|
Deere
|
Medtronic
|
Thermo Fisher
|
Eaton
|
Micron Technology
|
United Technologies
|
CEO Pay Design and Decisions
In establishing the 2020 compensation for the CEO, the Compensation Committee considered whether the value of the aggregate compensation package was consistent with its objectives for Linde’s executive compensation program, the material components of which are set forth in the company's Remuneration Policy. It evaluated the following factors when determining the compensation level for the CEO:
|
•
|
market median data of international companies traded on the U.S. stock exchanges
|
|
•
|
expected contribution to results, and exhibition of values, competencies and behaviors critical to the success of the Company
|
|
•
|
internal equity: respective role, responsibilities and reporting relationships
|
|
•
|
experience and time in similar roles
|
The Compensation Committee did not have a set formula for determining target compensation opportunity; however, it referred to the median benchmark data during its review. Additionally, the Compensation Committee acknowledged that its general practice will be to establish compensation levels toward the lower end of a competitive market range for an executive officer who is newer to his or her role. Conversely, a longer tenured executive officer with a history of strong performance will have target compensation levels set higher in the competitive range.
For 2020, 76% of the CEO’s target total direct compensation opportunity was in the form of performance-based variable compensation and equity grants, motivating him to deliver strong business performance and drive shareholder value.
The performance-based compensation is “at risk” and dependent upon the Company’s achievement of pre-established financial and other business goals set by the Compensation Committee and, for equity incentives, also the Company’s stock price performance. The annual variable compensation payout and the ultimate value of the performance-based equity compensation awards could be zero if the company does not perform.
Direct Compensation for CEO
Salary
While in January 2020 the Compensation Committee did approve, based on consideration of multiple factors including positioning to market, a salary increase to be made effective 1 April 2020, due to the COVID-19 pandemic, it was
Linde plc | Appendix 2-2
Appendix 2: Linde plc Directors’ Remuneration Report
subsequently decided to forgo any salary increases before they took effect. Therefore, the CEO annual salary rate that was established by the Committee in 2019 continued to remain in effect throughout 2020.
Annual Performance-Based Variable Compensation
The Compensation Committee established an annual performance-based variable compensation program for the 2020 calendar year that focuses the CEO and executives on the key objectives that position Linde for sustained growth, and the creation of shareholder value, without compromising long-term business objectives or encouraging excessive risk-taking. The Committee decided not to make any changes to the general design of the annual variable compensation program for the 2020 calendar year compared to 2019.
The annual variable compensation program is comprised of three main components: financial performance, strategic and non-financial performance and individual performance. This program is designed to deliver pay commensurate with performance wherein results that are greater than target goals are rewarded with above target payout levels, and performance not meeting minimum threshold expectations reduces the payout to zero.
Financial Performance Goals
Awards under the annual variable compensation program are determined based on company performance against challenging, pre-established financial goals. This component is weighted 75% of the total financial and non-financial payout, and payouts related to this component can range from zero to 200% of target variable compensation (for up to 150 percentage points). Top line sales growth is important to the company and 25% of the financial performance goal is based on sales. Recognizing the importance of profitability and cash flow to the Company, 50% of the financial performance goal is based on net income and the remaining 25% on operating cash flow.
To establish the goals related to the financial component of the program, the Compensation Committee considers many factors including the degree of control senior management may have over certain factors that affect financial performance. Goals are established with the expectation that the CEO and executives will be rewarded with higher payouts if actual performance exceeds targets. Factors considered in setting the threshold, target and maximum financial performance goals for each financial measure include:
|
•
|
synergy goals and expectations,
|
|
•
|
management’s operating plan, including expected year-over-year challenges in performance,
|
|
•
|
macro-economic trends and outlooks in each of the countries in which the company operates,
|
|
•
|
foreign exchange rate trends and outlook,
|
|
•
|
expected industrial gases industry peer performance and that of the broader S&P 500 and leading European companies,
|
|
•
|
shifts in key customer markets, and
|
|
•
|
expected contribution from contracts already awarded and decisions or actions already made or taken.
|
Strategic and Non-Financial Performance Goals
In alignment with the Company’s compensation philosophy and policy, the design of the annual variable compensation program balances the need for management to deliver annual results with the desire to meet multi-year growth expectations. Selected key strategic and non-financial performance objectives are included to recognize these critical measures of the Company’s health and potential for future success.
When establishing the 2020 program design, the Compensation Committee identified the strategic and non-financial elements that were considered most important to long-term sustainable success and established annual goals with respect to those elements. Most of the strategic and non-financial goals are linked to quantitative and measurable objectives, although the Compensation Committee uses its judgment when determining the value awarded for goal achievement after a rigorous review of the results. This component is weighted 25% of the total financial and non-financial payout, and payouts
Linde plc | Appendix 2-3
Appendix 2: Linde plc Directors’ Remuneration Report
related to this component can range from zero to 200% of target variable compensation (for up to 50 percentage points). The 2020 strategic and non-financial performance goals are as follows:
GOAL
|
ADDITIONAL DETAIL
|
Values: Safety, Compliance, Sustainability and Inclusion
|
|
• Zero fatalities with fatality potential event reduction
|
• Providing employees with a safe operating environment through investing in state of the art technology and by driving a culture in which safety is a top priority
|
• No significant process safety or environmental events
|
• Rigorous processes and procedures to ensure compliance with all applicable environmental regulations, to meet sustainable development performance targets and to continuously reduce the environmental impact of the Company’s operations in the communities in which it operates
|
• Best in class recordable injury, lost workday case and vehicle accident rates
|
• Create and maintain a strong ethical culture in every country where Linde operates
|
• Achieve world class performance in sustainability and continue progress toward greenhouse gas intensity reduction goals
|
• All employees accountable for ensuring that business results are achieved in compliance with local laws and regulations and the Company’s Code of Business Integrity
|
• A strong global compliance program and culture focusing on policies, procedures, training, reporting, accountability and verification via audit
|
• Attraction, retention and development of a diverse and engaged workforce through a robust succession planning process
|
• Strengthen leadership pipeline, including globally diverse talent, through a single succession planning and performance management approach across the enterprise
|
• Employee value proposition includes providing strong, dynamic leadership, a challenging work environment, industry-leading performance, competitive pay and benefits, and rewards and recognition for outstanding performance
|
Strategy:
|
|
• Position the business for long-term performance
|
• Deliver excellent results in the short-term and over a longer, sustainable period of time
|
• Continue with value capture from integration: cost and capex efficiencies, growth synergies and adoption of best practices
|
• Rigorously assess the quality and future impact of actions taken, as benefits may not be recognized for several years
|
• Maintain focus on operational excellence while ensuring growth by leveraging applications technology, optimizing product line portfolio, executing backlog, positioning for large projects, and capitalizing on decarbonization opportunities including green hydrogen
|
• Monitor the “health” of the organization through pulse surveys
|
• Enhance organizational capabilities in productivity tools, processes and practices
|
• Focus on meeting schedules and cost estimates, starting-up plants reliably and efficiently, and supporting plant availability
|
|
• Deliver value through continuous innovation to help Linde’s customers enhance their product quality, service, reliability, productivity, safety, and environmental performance
|
|
• Work across disciplines, industries and sectors, with employees, customers, suppliers and a range of other stakeholders to get more output utilizing fewer resources and with less environmental impact
|
Relative Performance:
|
|
• Strong performance relative to peer companies
|
• Continue to be the best performing industrial gases company in the world
|
|
• Determine if management’s actions appear more or less effective than those of Linde’s peers
|
|
• Assess how well we anticipate and manage adversity to optimize results
|
|
• Appropriately respond to macroeconomic or other external factors unknown at the time financial goals were established
|
Annual Performance-Based Variable Compensation Opportunity for 2020
The Compensation Committee established the 2020 variable compensation target for the CEO (expressed as a percent of salary that would be earned for 100% achievement of the performance goals). The target level for the CEO was 175% of base salary.
2020 Annual Performance-Based Variable Compensation Results and Payout
Financial Business Results
As noted above, financial goals are set considering multiple factors with the recognition that there are some items that cannot be easily predicted, and over which management has less control, such as foreign exchange rates and certain raw materials price changes. As part of the variable compensation plan design, certain pre-determined adjustments may be
Linde plc | Appendix 2-4
Appendix 2: Linde plc Directors’ Remuneration Report
made by the Compensation Committee to actual financial results in order to account for these elements. The Compensation Committee may also conclude that additional adjustments are appropriate based upon unforeseen factors it deems extraordinary, non-recurring or otherwise material.
The chart below shows for each financial performance measure, the 2020 Corporate financial targets set by the Compensation Committee and the actual performance achieved. The overall Corporate payout factor for financial performance was 116.5% of target variable compensation. The payout for the CEO is based on Linde plc Corporate results.
Financial Measure
|
2019
Actual
($ millions)
|
2020
Target
($ millions)
|
2020
Actual
($ millions)
|
Weight
|
Achievement
|
Payout
|
Sales*
|
28,473
|
28,070
|
27,297
|
25%
|
71%
|
17.9%
|
Net Income*
|
4,045
|
4,372
|
4,382
|
50%
|
103%
|
51.2%
|
Operating Cash Flow
|
6,119
|
6,833
|
7,429
|
25%
|
189%
|
47.4%
|
*For the annual variable compensation program, sales and net income are measured in accordance with GAAP subject to certain adjustments that the Compensation Committee approves.
Strategic Non-Financial Business Results
Coupled with its assessment of performance related to financial goals, the Compensation Committee reviewed the strategic actions taken by management that focused on long term sustainable success. After the end of the year, management presented to the Compensation Committee the degree of achievement in meeting each goal, and for each element, provided its view of the relative degree of importance to long term success.
Based on the results, the Compensation Committee determined that the Company’s performance with respect to the strategic and non-financial goals was favorable and set the Corporate strategic and non-financial payout factor at 160% of target variable compensation (relative to a 200% maximum). The Compensation Committee noted the following as examples of actions that support the Company’s strategic objectives in determining 2020 variable compensation payouts:
|
•
|
Maintained world class safety performance with a 10% reduction in commercial vehicle incidents
|
|
•
|
Managed COVID-19 pandemic through the following actions:
|
|
◦
|
Maintained operations: no disruptions, no internally generated spreader events, and managed transition to remote work (IT, Technology tools)
|
|
◦
|
Established Global Advisory Team in January to provide a global and consistent response:
|
|
▪
|
Interfaced with local pandemic coordinators
|
|
▪
|
Key Policies established: COVID-19 Safety Behaviors, Return to Work (four stage phased approach), and Testing & Quarantine Guidelines
|
|
◦
|
Significant number of heroic actions:
|
|
▪
|
Lincare caring for 40,000 COVID-19 patients
|
|
▪
|
Ramping up Oxygen supply, installing new Oxygen systems for COVID hospital surge
|
|
▪
|
Drivers delivering to customers into “Hot/Red” zones
|
|
▪
|
Plant operators living at plants to maintain operations
|
|
•
|
Delivered productivity of $860 million, 24% above plan target
|
|
•
|
Created over $150 million impact from digitalization, including new technologies and best practices adoption
|
|
•
|
Completed first annual training and certification of Company’s new Code of Business Integrity with 100% of targeted employees
|
|
•
|
Trained approximately 1,200 leaders of the company on Unconscious Bias
|
|
•
|
Capitalized on decarbonization opportunities by developing over $100 million of projects in EMEA that relate to decarbonization
|
|
•
|
Received Public Recognition:
|
|
◦
|
Dow Jones Sustainability World Index: only chemical company recognized for 18 consecutive years
|
|
◦
|
MSCI ESG Rating upgraded to “A”
|
|
◦
|
Consistently listed on major Diversity and Inclusion indices: Bloomberg’s Gender Equality Index, Forbes Best Employer for Diversity, Financial Times Diversity Leaders and Human Rights Campaign Corporate Equality Index
|
|
◦
|
Recognized as Top Noteworthy company by DiversityInc.
|
Linde plc | Appendix 2-5
Appendix 2: Linde plc Directors’ Remuneration Report
Set forth below is the calculation of the CEO’s 2020 variable compensation payout determined in accordance with the criteria described above. The variable compensation paid to the CEO in 2020 accounted for 19% of the CEO’s total compensation with fixed compensation accounting for 27% of the CEO’s total compensation for the year.
CEO Actual VC
Calculation
|
2019
Actual VC Amount
|
2020
Target VC Amount
|
2020
Corporate VC Payout Factor
|
2020
Actual VC Amount
|
|
$3,726,422
|
$2,703,750
|
127.3%
|
$3,441,874
|
2020 Equity Awards Design
Equity awards are the largest portion of the CEO’s target compensation. This weighting helps ensure a strong alignment of the CEOs’ and shareholders’ long-term interests. Annual grants of equity awards are made to incent and reward sustained performance. Equity awards are granted as a mix of stock options, performance share units (PSUs) and restricted stock units (RSUs). The mix and type of equity awards granted to the CEO is the same as those granted to all eligible executives of the Company. Fully aligning the leadership team, from mid-management to officers, helps sustain the Company’s pay for performance culture by incenting and rewarding all participants with the same goals and performance results.
Performance Share Units (50% of award target value)
The Compensation Committee includes PSUs in its award mix as this vehicle focuses executives on the Company’s mid-term performance objectives. A three-year performance period is believed to be an appropriate balance between the one-year performance-based variable compensation goals and the longer-term stock option share price growth goals. Additionally, the overlapping three-year performance periods that result from regular annual grants promote retention and encourage management to focus on sustainable growth and shareholder returns. Key features of the PSUs include:
|
•
|
Vest if pre-established multi-year performance goals are attained and forfeited if threshold goals are not met.
|
|
•
|
Pay no dividends nor accrue dividend equivalents prior to vesting.
|
|
•
|
Require executives to hold all after-tax shares derived from vested awards until their respective stock ownership requirement is met.
|
The Committee determined that using a Return on Capital (ROC) performance goal would be appropriate as it encourages and rewards the executive team for focusing decisions and taking actions that drive long term ROC performance. A relative Total Shareholder Return (TSR) goal was also considered appropriate as this portion of the equity award will further strengthen alignment of management payouts with shareholder returns. In order to align with the Company’s global shareholder base, it was determined that TSR performance would be measured against a blended group of companies that is comprised of those that are listed on the S&P 500, excluding the Financial sector, plus those that are designated as Eurofirst 300 at 1 January 2020.
Stock Options (30% of award target value)
The Compensation Committee believes that stock options present an appropriate balance of risk and reward in that the options have no value unless the Company’s stock price increases above the option exercise price and that the opportunity to realize value from growth in shareholder value over the ten-year grant term encourages long term decision-making. The Compensation Committee notes that the Company’s executives place a high value on stock options as a compensation vehicle. Key features of the stock options include:
|
•
|
Exercise price is fixed at 100% of the closing market price on date of grant.
|
|
•
|
Vest in equal annual tranches over three years and expire after ten years.
|
|
•
|
No repricing without shareholder approval.
|
|
•
|
Require executives to hold all shares obtained from exercise, net of taxes and exercise price, until their respective stock ownership requirement is met
|
Restricted Stock Units (20% of award target value)
The Compensation Committee recognizes that RSUs can provide appropriate rewards to executives through alignment with the Company’s stock price. The RSUs are the smallest component of the equity award mix, and cliff vest three years after
Linde plc | Appendix 2-6
Appendix 2: Linde plc Directors’ Remuneration Report
their grant date to aid NEO retention. RSUs can also mitigate some of the impact of an economic downturn on the PSU and stock option components of the annual awards. Key features of the RSUs include:
|
•
|
Pay no dividends nor accrue dividend equivalents prior to vesting.
|
|
•
|
Require executives to hold all after-tax shares derived from vested awards until their respective stock ownership requirement is met
|
2020 Equity Award Grants
The Compensation Committee established the target dollar value of 2020 equity awards for the CEO (and each NEO). The Compensation Committee examined relative responsibility of the executive officers and the CEO’s position to market with consideration of how long he or she had been in the current role. Particular emphasis was placed on the importance of providing the CEO with incentive and appropriate reward for taking high quality actions to support sustainable long-term growth.
ROC-measured performance share units
The ROC goal for the PSU awards covering fiscal years 2020 - 2022 was determined after the Compensation Committee examined prior-year ROC results, industry ROC averages, capital expenditure projections and the Company’s weighted average cost of capital. The payout schedule was set with the intent of encouraging and rewarding the executive team for taking actions that result in industry-leading ROC performance. The March 2020 awards are measured against the following ROC goals:
2020-2022
|
Average Annual ROC
|
Payout*
|
Below Threshold
|
<11.7%
|
0%
|
Threshold
|
11.7%
|
50%
|
Target
|
13.0%
|
100%
|
Maximum
|
≥14.0%
|
200%
|
*Interpolated for results between threshold and maximum.
ROC is the Company's after-tax return on capital as reported in its quarterly and annual Consolidated Financial Statements, adjusted to eliminate the after-tax effect of any acquisition occurring during the Performance Period that was not known at the time the goals were set.
Relative TSR-measured performance share units
The March 2020 Relative TSR awards are measured against a blended group of companies that is comprised of those that are listed on the S&P 500, excluding the Financial sector, plus those that are designated as Eurofirst 300 at 1 January 2020, and payouts will be determined based on the following schedule:
2020-2022
|
TSR Rank
|
Payout*
|
Below Threshold
|
<25%ile
|
0%
|
Threshold
|
25%ile
|
25%
|
Target
|
50%ile
|
100%
|
Maximum
|
≥75%ile
|
200%
|
*Interpolated for results between threshold and maximum.
Legacy Praxair 2020 Equity Award Payouts
As detailed in the Business Combination Agreement, at the time of merger, each outstanding Praxair PSU was converted into a company RSU with the number of shares subject to the replacement award equal to the greater of (i) the target number of shares subject to the Praxair PSU or (ii) the number of shares determined based upon the achievement of the performance goals immediately prior to the effective time of the merger, as determined by the Praxair Compensation Committee. In February 2020, the replacement RSUs from the 2017 Praxair PSU grants vested. Below are the
Linde plc | Appendix 2-7
Appendix 2: Linde plc Directors’ Remuneration Report
conversion rates for those awards that were directed by the Praxair Compensation Committee at the time of merger and applied to the 2017 Praxair PSU grants to determine the number of company RSUs that vested in February 2020.
Legacy Praxair PSU Awards
|
Target
|
Actual Performance at Merger
|
Conversion Rate
|
2017 through 2019 relative TSR
|
50%ile
|
75.5%ile
|
200%
|
2017 to 2019 average annual ROC
|
12.5%
|
13.1%
|
160%
|
CEO Compensation Table
The table below presents compensation information for the CEO and includes footnotes and other narrative explanations important for understanding of the compensation information in the table. The Summary Compensation Table summarizes key components of the CEO compensation for 2019 and 2020. The tables following the Summary Compensation Table provide more detailed information about the various types of CEO compensation for 2020, some of which are included in the Summary Compensation Table.
Name and Principal Position
|
Year
|
Salary
($)(1)
|
Stock
Awards
($)(2)
|
Option
Awards
($)(2)
|
Non-equity
Incentive Plan
Compensation
($)(3)
|
Change in
Pension Value and
Nonqualified
Deferred
Compensation
Earnings
($)(4)
|
All Other
Compensation
($)(5)
|
Total
($)
|
Stephen F. Angel,
|
2020
|
1,545,000
|
7,880,305
|
2,950,344
|
3,441,874
|
2,474,000
|
265,378
|
18,556,901
|
Chief Executive Officer
|
2019
|
1,520,833
|
9,121,847
|
4,152,405
|
3,726,422
|
3,596,000
|
358,371
|
22,475,878
|
(1) Amounts reported are actual salaries paid for the calendar year and include adjustments to base salary rates if applicable.
(2) These amounts were not paid in the respective year but rather are the full grant date fair value of equity awards made for each year as determined under accounting standards related to share-based compensation. The Stock Awards amounts are the value for the PSU grants made in 2019 and 2020 to the CEO valued at the target number of shares granted and the values of RSU grants made to the CEO in each year. The Option Awards amounts are the values for options granted in each year. The assumptions used in computing the Options Awards and Stock Awards amounts are included in Note 15 to the Company's 2020 financial statements in the 2020 Form 10-K and Annual Report. The amounts shown in the Stock Awards and Option Awards columns are subject to vesting conditions that may or may not result in actual payouts in future years. In addition, a stock option has value only if the Company's stock price increases above the option exercise price (an "in-the-money" option). If the CEO exercises an in-the-money option, he would then realize an actual gain. Any gain realized for options exercised in 2020 and the value realized in connection with RSUs that vested in 2020, are reported in the "2020 Option Exercises and Stock Vested" table.
(3) The CEO was paid a performance-based variable compensation payment in 2021 based upon the Company's 2020 performance, and in 2020 based upon the Company's 2019 performance. These amounts are reported as "Non-equity Incentive Plan Compensation".
(4) Amounts in this column are the annual increase in actuarial present value of retirement benefits payable under the Company's Pension Program. These amounts were not actually paid to the CEO. The total pension present value accrued for the CEO through 2020 is disclosed in the 2020 Pension Benefits Table.
(5) This column includes any perquisites or personal benefits that exceeded $10,000 for the CEO during 2020, value at incremental costs. The CEO was not reimbursed for any taxes due based on the imputed value of Company-provided perquisites or personal benefits not generally available to all employees. Such perquisites or personal benefits were:
Year
|
Matching Contribution
|
Personal Use of Company Aircraft
|
Financial Planning
|
Other
|
2020
|
57,038
|
193,816
|
13,525
|
1,000
|
2019
|
53,375
|
290,336
|
13,660
|
1,000
|
Linde plc | Appendix 2-8
Appendix 2: Linde plc Directors’ Remuneration Report
Matching Contribution includes Company contributions to the Company's U.S. 401(k) Plan and Company contributions to the U.S. Compensation Deferral Program described under the "2020 Nonqualified Deferred Compensation" table below. For reasons of security and time management, the Board requires the CEO to use the Company's corporate aircraft for personal use as well as business travel. The aircraft is available for the Company's use through a time-share arrangement with a fixed time-share charge for the right to use the aircraft and a per-trip charge. The Company calculates the incremental aircraft costs for Mr. Angel's personal use as the full amount of those per-trip charges attributable to his personal use. The fixed time-share charge is not included as an incremental cost, as the Company must pay this amount even if Mr. Angel does not use the aircraft for personal travel. Other perquisites include U.S Health Savings Account Contributions.
2020 Grants of Plan-Based Awards
Below is information regarding the 2020 Non-Equity Incentive Plan Compensation, Stock Awards and the Option Awards reported in the Summary Compensation Table above. The 2020 option grants, performance share unit (PSU) and restricted stock unit (RSU) awards reported in the table below were made under the Amended and Restated 2009 Linde Long Term Incentive Plan. The awards granted to the CEO were made on substantially the same terms as the 2020 grants that were made to all other eligible employees.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Possible Payouts Under Non-Equity Incentive Plan Awards
|
|
Estimated Future Payouts Under Equity Incentive Plan Awards
|
|
|
|
|
|
Grant Date
(1)
|
Com-pensation Commitee Approval Date
(1)
|
Thre-shold
($)
|
Target
($)
|
Maxi-mum
($)
|
|
Thre-shold
(#)
|
Target
(#)
|
Maxi-mum
(#)
|
All other Stock Awards: Number of Shares of Stock or Units
(#)
|
All Other Option Awards: Number of Securities Under-lying Options
(#)
|
Exer-cise or Base Price of Option Awards
($/Sh)
|
Grant Date Fair Value of Stock and Option Awards
($)(6)
|
2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variable Cash (2)
|
|
|
0
|
2,703,750
|
5,407,500
|
|
|
|
|
|
|
|
|
Stock Options (3)
|
3/9/2020
|
2/24/2020
|
|
|
|
|
|
|
|
|
169,560
|
173.13
|
2,950,344
|
RSUs (4)
|
3/9/2020
|
2/24/2020
|
|
|
|
|
|
|
|
13,935
|
|
|
2,253,708
|
ROC PSUs (5)
|
3/9/2020
|
2/24/2020
|
|
|
|
|
0
|
20,900
|
41,800
|
|
|
|
3,380,157
|
TSR PSUs (5)
|
3/9/2020
|
2/24/2020
|
|
|
|
|
0
|
11,300
|
22,600
|
|
|
|
2,246,440
|
2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variable Cash
|
|
|
0
|
2,509,375
|
5,018,750
|
|
|
|
|
|
|
|
|
Stock Options
|
3/20/2019
|
2/25/2019
|
|
|
|
|
|
|
|
|
177,605
|
176.63
|
4,152,405
|
RSUs
|
3/20/2019
|
2/25/2019
|
|
|
|
|
|
|
|
15,755
|
|
|
2,628,407
|
ROC PSUs
|
5/1/2019
|
2/25/2019
|
|
|
|
|
0
|
23,630
|
47,260
|
|
|
|
3,980,946
|
TSR PSUs
|
5/1/2019
|
2/25/2019
|
|
|
|
|
0
|
11,640
|
23,280
|
|
|
|
2,512,494
|
(1) On February 24, 2020, the Company's Compensation Committee approved the stock options, PSUs and RSUs to be granted to NEOs. It set March 9, 2020 as the actual grant date for all award types.
(2) The actual amount of performance-based variable compensation payable in March 2021 for 2020 performance is shown in the "Summary Compensation Table" under "Non-Equity Incentive Plan Compensation". The amounts shown in these columns in the table above are the range of potential 2020 payments that could have been made.
(3) These are the number of shares underlying stock option grants made in March 2020.
(4) This is the number of restricted stock units granted in March 2020.
Linde plc | Appendix 2-9
Appendix 2: Linde plc Directors’ Remuneration Report
(5) These are the threshold, target and maximum number of shares that may be earned under PSU awards made in March 2020.
(6) The amounts are the full grant date fair values of the RSU awards, PSU awards, and the stock option grants made in 2020, calculated in accordance with accounting standards related to share-based compensation. The values for the PSU awards are based on the target number of shares granted. These amounts are neither paid to any NEO nor equal to the amounts recognized by the Company as compensation expense in 2020.
2020 Outstanding Equity Awards at Fiscal Year-End
The table below shows the CEO’s outstanding equity awards at the end of 2020. The material terms of the awards are described under the caption “2020 Equity Award Grants” above and in the footnotes to the table below.
|
Option Awards
|
|
Stock Awards
|
|
Number of Securities Underlying Unexercised Options (#) Exercisable (1)
|
Number of Securities Underlying Unexercised Options (#) Unexercisable (1)
|
Option Exercise Price ($)(2)
|
Option Grant Date
|
Option Expiration Date
|
|
Number of Shares or Units of Stock That Have Not Vested (#)(3)
|
Market Value of Shares or Units of Stock That Have Not Vested ($)(4)(5)
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)(6)
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (#)(4)
|
At 31st December 2020
|
261,075
|
0
|
128.38
|
2/24/2015
|
2/24/2025
|
|
67,960
|
17,908,140
|
67,470
|
17,779,020
|
|
416,355
|
0
|
102.22
|
2/23/2016
|
2/23/2026
|
|
|
|
|
|
|
435,850
|
0
|
118.71
|
2/28/2017
|
2/26/2027
|
|
|
|
|
|
|
212,520
|
106,260
|
154.00
|
2/27/2018
|
2/25/2028
|
|
|
|
|
|
|
59,201
|
118,404
|
176.63
|
3/20/2019
|
3/20/2029
|
|
|
|
|
|
|
0
|
169,560
|
173.13
|
3/9/2020
|
3/8/2030
|
|
|
|
|
|
At 31st December 2019
|
187,015
|
0
|
110.58
|
2/26/2013
|
2/24/2023
|
|
134,237
|
28,579,057
|
35,270
|
7,508,983
|
|
203,930
|
0
|
128.80
|
2/25/2014
|
2/23/2024
|
|
|
|
|
|
|
261,075
|
0
|
128.38
|
2/24/2015
|
2/24/2025
|
|
|
|
|
|
|
416,355
|
0
|
102.22
|
2/23/2016
|
2/23/2026
|
|
|
|
|
|
|
290,566
|
145,284
|
118.71
|
2/28/2017
|
2/26/2027
|
|
|
|
|
|
|
106,260
|
212,520
|
154.00
|
2/27/2018
|
2/25/2028
|
|
|
|
|
|
|
0
|
177,605
|
176.63
|
3/20/2019
|
3/20/2029
|
|
|
|
|
|
(1) Each stock option vests in three consecutive equal annual installments beginning on the first anniversary of the grant date.
(2) The exercise price for all stock options is the closing price on the NYSE on the date of grant.
(3) This column includes the number of shares underlying the RSU awards granted to the CEO on March 20, 2019 and March 9, 2020. Also, included are the Company RSU awards that were provided in place of outstanding Praxair 2018 RSU awards upon the merger. The portion of awards that replaced the 2018 RSUs vested on February 27, 2021.
(4) The market value reported in this column is the number of unvested restricted stock units multiplied by the $263.51 December 31, 2020 closing price of the Company's common stock as reported on the NYSE.
(5) Where applicable under U.S. tax law, the Company collects from NEOs and pays Federal Insurance Contributions Act (FICA) taxes on awards.
(6) This column includes the target number of PSUs granted in May 2019 and March 2020.
Linde plc | Appendix 2-10
Appendix 2: Linde plc Directors’ Remuneration Report
2020 Option Exercises and Stock Vested
This table provides information about any stock options that were exercised by the CEO and restricted stock units that vested during 2020.
|
Option Awards
|
|
Stock Awards
|
|
Number of Shares Acquired on Exercise (#)
|
Value Realized on Exercise ($)(1)
|
|
Number of Shares Acquired on Vesting (#)(2)
|
Value Realized on Vesting ($)(2)
|
2020
|
390,945
|
52,942,148
|
|
80,212 (3)
|
15,321,294 (3)
|
2019
|
454,685
|
39,821,790
|
|
59,795 (3)
|
10,374,433 (3)
|
(1) The option exercise value realized for 2020 equals the (i) NYSE market price of the Company's common stock at the time of the option exercise minus the option exercise price, multiplied by (ii) the option shares exercised. All amounts reported are before taxes.
(2) The values represent shares acquired pursuant to the vesting and payout in February 2020 of the Company RSU awards that replaced the Praxair 2017 PSU awards outstanding at the time of the business combination.
In all cases, the value of the shares is before taxes and equals the number of shares paid out multiplied by the NYSE closing price of the Company's common stock on the applicable vesting dates.
(3) The amounts reported for Mr. Angel were not paid to him in 2020 because he previously made a voluntary election to defer payment of shares in settlement of his vested RSU award until a future date. See the "2020 Nonqualified Deferred Compensation" table for more information.
2020 Pension Benefits
The table below shows certain retirement benefit information of the CEO under the Company’s Pension Programs and agreements.
|
Plan Name(1)
|
Number of Years of Credited Service
(#)
|
Present Value of Accumulated Benefit ($)(2)
|
Payments During Last Fiscal Year
($)
|
2020 (3)
|
Linde U.S. Pension Plan
|
20
|
1,181,000
|
0
|
|
Supplemental Retirement Income Plan
|
41
|
8,192,000
|
0
|
2019
|
Linde U.S. Pension Plan
|
19
|
1,050,000
|
0
|
|
Supplemental Retirement Income Plan
|
40
|
5,849,000
|
0
|
(1) Mr. Angel participates in the Linde U.S. Pension Program's Traditional Design component.
(2) See the narrative after the table for a description of the Present Value of Accumulated Benefit. The values for each plan listed above are additive.
(3) The Linde U.S. Pension Plan credited years of service for Mr. Angel represent his actual years of service with the Company.The Supplemental Retirement Income Plan credited years of service adds the recognition of Mr. Angel's 21.64 years of prior General Electric service. In connection with Mr. Angel's recruitment to the Company in 2001 and in order to provide him with a retention incentive, the Company agreed to provide Mr. Angel with credit under the Linde Inc. Supplemental Retirement Income Plans (collectively referred to as the "SRIP") to recognize his years of service with his prior employer, General Electric. The receipt of this additional credited service was subject to time-based vesting requirements which were satisfied in 2016. The Company has recognized as an accrued pension liability, the additional years of service credit that Mr. Angel received under the SRIP over the course of his anticipated years of service, and no future accruals are expected as the liability has been fully accrued and the years of service credit fully vested. When Mr. Angel retires, he will receive retirement benefits under the Pension Program based on his Company service plus the additional years of recognized General Electric service, less offsets for the benefits paid pursuant to the SRIP in connection with the business combination (see Note 6 to the "Summary Compensation Table" above and the detailed description of the Pension Program below) and the benefits he receives under the General Electric retirement plans. The values shown above include the effect of these offsets. If Mr. Angel is terminated for cause (as defined in the service credit agreement) he will forfeit recognition of his prior General Electric service and value attributed to this service to the extent previously paid may be recouped by the Company.
Linde plc | Appendix 2-11
Appendix 2: Linde plc Directors’ Remuneration Report
Present Value of Accumulated Benefit
The 2020 Pension Benefits table includes a “Present Value of Accumulated Benefit.” This is the value in today’s dollars of the total expected future retirement benefits that the CEO may receive under the Pension Program, and these are accrued amounts as of the end of 2020. For any given year, there will be a change in the accumulated benefit. For example, from one year to the next, the accumulated benefit may increase because the CEO has worked for an additional year and received credit for that or his pensionable earnings have increased. The accumulated benefit may also increase or decrease based on the interest rate used to calculate the present value of the CEO’s retirement payments compared to the prior year. The annual change in accumulated benefit is disclosed in the “CEO Compensation Table” in the “Change in Pension Value” column.
The company recognizes these amounts as a future pension liability on its financial statements. The company calculates these amounts using complex actuarial valuations and assumptions. These assumptions are described in Note 16 to the Company’s 2020 financial statements in the 2020 Form 10-K and Annual Report. However, as required by SEC rules, the 2020 Pension Benefits table assumes that the CEO will retire at the earliest retirement age that would provide full (unreduced) benefits. The value in today’s dollars of the total retirement benefits that the CEO eventually receives may be more or less than the amount shown in the 2020 Pension Benefits table.
2020 Nonqualified Deferred Compensation
This table shows information regarding compensation amounts that (i) the CEO decided not to receive in cash but elected to defer to a later date under the U.S. Linde Compensation Deferral Program, (ii) are company contributions to the Compensation Deferral Program; or (iii) shares payable in settlement of a vested PSU or RSU award that the CEO elected to defer to a later date pursuant to the terms of the Amended and Restated 2009 Linde Long Term Incentive Plan and the applicable award agreements.
|
Executive Contributions in Last Fiscal
Year ($)(1)
|
Company Contributions in Last Fiscal
Year ($)(2)
|
Aggregate Earnings in Last Fiscal
Year ($)
|
Aggregate Withdrawals/Distributions
($)
|
Aggregate Balance at Last Fiscal Year End
($)(3)
|
2020
|
19,047,716
|
47,250
|
16,686,605
|
0
|
71,679,932
|
2019
|
15,344,855
|
46,531
|
8,671,440
|
0
|
35,899,080
|
(1) These amounts are voluntary deferrals elected by Mr. Angel under Linde's U.S. Compensation Deferral Program of the variable compensation for the 2020 plan year paid in March 2021 under the Company's Variable Compensation Plan. These amounts are included in the "Non-equity Incentive Plan Compensation" in the "CEO Compensation Table" above. The amount shown also includes the value of the Company shares that would have been paid to Mr. Angel in settlement of the RSU award that vested in February 2020 in the absence of his prior election to defer the payment of these shares until a later date.
(2) These amounts are the Company contributions for the CEO made in 2021 for 2020. These amounts are included in "All Other Compensation" in the "CEO Compensation Table".
(3) Balances are net of prior payouts and otherwise are the total of (i) all compensation that the CEO previously elected to defer (ii) Company contributions made to the U.S. Compensation Deferral Program on behalf of the CEO, and (iii) any notional investment earnings on these amounts. The balances are not amounts paid in 2020.
Remuneration of Non-Executive Directors
The compensation paid to our non-executive directors for the fiscal years ended 31 December 2020 and 2019 is reported in the tables below. The compensation paid to non-executive directors includes an element of equity-based compensation, designed to provide greater alignment of interests between non-executive directors and the Company's shareholders. This equity-based compensation is not subject to the achievement of performance metrics given the nature of the role performed by the non-executive directors, but is subject to a one-year time vesting requirement from the date of grant. Stephen F. Angel is the only executive director currently on the Board. While serving as executive director, Mr Angel receives no
Linde plc | Appendix 2-12
Appendix 2: Linde plc Directors’ Remuneration Report
additional compensation for his service as director and accordingly is not included in the following tables or discussion. All other members of the Board are non-executive directors.
Name
|
2020
Fees Earned or
Paid in Cash
($)
|
2020
Stock
Awards
($)(1)
|
2020
Other
Compensation
($)(2)
|
2020
Total
($)
|
Prof. Dr. Wolfgang H. Reitzle
|
450,000
|
321,510
|
5,000
|
776,510
|
Prof. DDr. Ann-Kristin Achleitner
|
180,000
|
128,646
|
5,000
|
313,646
|
Prof. Dr. Clemens A. H. Borsig
|
280,000
|
128,646
|
5,000
|
413,646
|
Dr. Nance K. Dicciani
|
180,000
|
128,646
|
15,000
|
323,646
|
Dr. Thomas Enders
|
180,000
|
128,646
|
5,000
|
313,646
|
Franz Fehrenbach
|
180,000
|
128,646
|
5,000
|
313,646
|
Edward G. Galante
|
230,000
|
128,646
|
5,000
|
363,646
|
Larry D. McVay
|
180,000
|
128,646
|
6,000
|
314,646
|
Dr. Victoria E. Ossadnik
|
180,000
|
128,646
|
5,000
|
313,646
|
Prof. Dr. Martin H. Richenhagen
|
180,000
|
128,646
|
5,000
|
313,646
|
Robert L. Wood
|
230,000
|
128,646
|
5,000
|
363,646
|
TOTAL:
|
2,450,000
|
1,607,970
|
66,000
|
4,123,970
|
(1) Full grant date fair value of restricted stock units granted to each director on February 24, 2020 as determined under U.S GAAP accounting standards related to share-based compensation.
(2) Amounts in this column do not represent cash or stock compensation paid to the directors. These amounts are the value of the following benefits provided to the directors by the Company: (a) $15,000 for Ms. Dicciani and $1,000 for Mr. McVay as 2020 matching contributions for their eligible personal charitable contributions pursuant to the Company's charitable matching gift program that matches personal donations to eligible charitable institutions up to a $15,000 maximum per year per donor, and (b) $5,000 for each director except Ms. Dicciani for fees paid by the Company for the preparation and filing of director's personal tax returns in the United Kingdom with respect to the taxation of directors' compensation in the United Kingdom.
Name
|
2019
Fees Earned or
Paid in Cash ($)
|
2019
Stock Awards
($)(1)
|
2019
Other
Compensation
($)(2)
|
2019
Total
($)
|
Prof. Dr. Wolfgang H. Reitzle
|
420,000
|
307,821
|
—
|
727,821
|
Prof. DDr. Ann-Kristin Achleitner
|
180,000
|
131,998
|
—
|
311,998
|
Prof. Dr. Clemens A. H. Borsig
|
280,000
|
131,998
|
—
|
411,998
|
Dr. Nance K. Dicciani
|
180,000
|
131,998
|
15,000
|
326,998
|
Dr. Thomas Enders
|
180,000
|
131,998
|
—
|
311,998
|
Franz Fehrenbach
|
180,000
|
131,998
|
—
|
311,998
|
Edward G. Galante
|
230,000
|
131,998
|
—
|
361,998
|
Larry D. McVay
|
180,000
|
131,998
|
1,000
|
312,998
|
Dr. Victoria E. Ossadnik
|
180,000
|
131,998
|
—
|
311,998
|
Prof. Dr. Martin H. Richenhagen
|
180,000
|
131,998
|
—
|
311,998
|
Robert L. Wood
|
230,000
|
131,998
|
—
|
361,998
|
TOTAL:
|
2,420,000
|
1,627,801
|
16,000
|
4,063,801
|
(1) Full grant date fair value of restricted stock units granted to each director on February 26, 2019 as determined under U.S. GAAP accounting standards related to share-based compensation.
(2) Amounts in this column do not represent compensation paid to the directors. These amounts are the Company's 2019 matching contributions for the directors' eligible charitable donations. In 2019, Linde matched personal donations to
Linde plc | Appendix 2-13
Appendix 2: Linde plc Directors’ Remuneration Report
eligible charitable institutions up to a $15,000 maximum per year per donor. This matching gift program is available to Company employees and non-management directors on the same basis.
Director Expenses
Directors are entitled to reimbursement for travel and other expenses incurred on behalf of the company in accordance with the Linde plc Directors Travel and Expenses Policy or pursuant to other Board-approved policies.
Time-vested restricted shares
The following table sets forth information regarding the number and amount of restricted share awards outstanding at the beginning and end of the fiscal year ended 31 December 2020 for each director serving on the Board during 2020:
Name
|
Date of Grant
|
End of Period Over Which Qualifying Conditions Must be Fulfilled for Each
Award
|
Restricted Units Outstanding at Beginning of
FY 2020
(#)(1)
|
Restricted Units Granted During
FY 2020
(#)(2)
|
Restricted Units Vested During
FY 2020
(#)
|
Market Price Per Share on Date of Grant
(3)
|
Market Price Per Share on Vesting of Award
(4)
|
Income realized Upon Vesting
(5)
|
Restricted Units Outstanding at End of FY
2020 (#)(1)
|
Prof. Dr. Wolfgang H. Reitzle
|
2/26/2019
|
2/26/2020
|
1,770
|
1,527
|
1,802
|
$173.91
|
$203.41
|
$366,641.85
|
1,556
|
Prof. DDr. Ann-Kristin Achleitner
|
2/26/2019
|
2/26/2020
|
759
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
622
|
Prof. Dr. Clemens A. H. Borsig
|
2/26/2019
|
2/26/2020
|
759
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
622
|
Dr. Nance K. Dicciani
|
2/26/2019
|
2/26/2020
|
6,778
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
6,755
|
Dr. Thomas Enders
|
2/26/2019
|
2/26/2020
|
759
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
622
|
Franz Fehrenbach
|
2/26/2019
|
2/26/2020
|
759
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
622
|
Edward G. Galante
|
2/26/2019
|
2/26/2020
|
8,677
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
8,689
|
Larry D. McVay
|
2/26/2019
|
2/26/2020
|
5,472
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
5,424
|
Dr. Victoria E. Ossadnik
|
2/26/2019
|
2/26/2020
|
759
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
622
|
Prof. Dr. Martin H. Richenhagen
|
2/26/2019
|
2/26/2020
|
759
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
622
|
Robert L. Wood
|
2/26/2019
|
2/26/2020
|
2,950
|
611
|
773
|
$173.91
|
$203.41
|
$157,221.08
|
2,855
|
(1) Includes all other RSU awards granted to directors Dicciani, Galante, McVay and Wood during their service as directors of Praxair, Inc. prior to the business combination, that have fully vested but whose payment in Linde plc Ordinary Shares has been deferred by the director until termination of service as a director or a specific future date.
(2) Restricted stock units were granted on February 24, 2020 and vesting one year later.
(3) Closing price per share of Linde plc ordinary shares on the February 26, 2019 grant date with respect to the 2019 RSU grant.
(4) Closing price per share of Linde plc ordinary shares on the February 26, 2020 vesting date with respect to the 2019 RSU grant.
(5) Income realized equals the number of RSUs vested and paid out multiplied by the closing price per share of Linde ordinary shares on the February 26, 2020 vesting date.
Linde plc | Appendix 2-14
Appendix 2: Linde plc Directors’ Remuneration Report
Statement of change in pay of employees
The table below summarizes the percentage change in average remuneration of our employees (on a full time equivalent basis and excluding our directors) for fiscal years 2019 and 2020.
Employees Other than Executive Directors
|
2020 Average Total
Remuneration ($)
|
2019 Average Total
Remuneration ($)
|
Percentage Change in 2020
Compared with 2019
|
48,701
|
48,556
|
0.3%
|
Linde plc | Appendix 2-15
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Appendix 3: 2021 Linde plc Long Term Incentive Plan
|
2021 Linde plc
Long Term Incentive Plan
Effective as of July 26, 2021
|
Linde plc | Appendix 3-1
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Table of Contents
Article 1.
|
Establishment, Purpose, and Duration
|
Article 2.
|
Definitions
|
Article 3.
|
Administration
|
Article 4.
|
Shares Subject to this Plan and Maximum Awards
|
Article 5.
|
Eligibility and Participation
|
Article 6.
|
Stock Options
|
Article 7.
|
Stock Appreciation Rights
|
Article 8.
|
Restricted Stock Grants
|
Article 9.
|
Performance Units
|
Article 10.
|
Other Stock-Based Awards
|
Article 11.
|
Transferability of Awards
|
Article 12.
|
Performance Measures
|
Article 13.
|
Dividend Equivalents
|
Article 14.
|
Termination of Employment or Service as a Director
|
Article 15.
|
Rights of Participants
|
Article 16.
|
Change in Control
|
Article 17.
|
Amendment, Modification, Suspension, and Termination
|
Article 18.
|
Tax Withholding; No Liability with Respect to Tax Qualification or Adverse Tax Treatment
|
Article 19.
|
Successors
|
Article 20.
|
General Provisions
|
|
|
Linde plc | Appendix 3-2
Appendix 3: 2021 Linde plc Long Term Incentive Plan
2021 Linde plc
Long Term Incentive Plan
(Effective as of July 26, 2021)
Article 1.
|
Establishment, Purpose, and Duration
|
1.1Establishment. Linde plc, an Irish public limited company (hereinafter referred to as the “Company”), hereby adopts its 2021 Linde plc Long Term Incentive Plan (hereinafter referred to as the “Plan”), as set forth in this document.
This Plan permits the grant of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights (“SARs”), Restricted Stock, Restricted Stock Units, Performance Units, and Other Stock-Based Awards. This Plan was adopted by the Board on April 26, 2021 and shall become effective upon shareholder approval on July 26, 2021 (the “Effective Date”) and shall remain in effect as provided in Section 1.3 hereof. As of the Effective Date, no new awards shall be granted or awarded under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan (the “Legacy Plan”) and any authorized Shares that remain available for grant under new awards thereunder shall be cancelled. Any awards granted under the Legacy Plan (whether vested or unvested) prior to the Effective Date shall remain outstanding under such plan in accordance with their terms and this Plan shall not affect the terms or conditions of any such award.
1.2Purpose of this Plan. The purpose of this Plan is to provide a means whereby Employees develop personal involvement in the financial success of the Company, and to encourage them to devote their best efforts to the business of the Company, thereby advancing the interests of the Company and its shareholders. A further purpose of this Plan is to provide a means through which the Company may attract and retain able Employees and to provide a means whereby those individuals can acquire and maintain stock ownership, thereby strengthening their concern for the welfare of the Company. This Plan also provides a means of compensating Directors in the form of equity as a complement to other elements of the Directors’ overall compensation program and to align their interests with those of the Company’s shareholders.
1.3Duration of this Plan. Unless sooner terminated as provided herein, this Plan shall terminate July 25, 2031. After this Plan is terminated, no Awards may be granted but Awards previously granted shall remain outstanding in accordance with their applicable terms and conditions and this Plan’s terms and conditions.
Whenever used in this Plan, the following terms shall have the meanings set forth below, and when the meaning is intended, the initial letter of the word shall be capitalized.
2.1“Acquisition Awards” has the meaning set forth in Section 4.2.
2.2“Administrator” has the meaning set forth in Section 3.5.
2.3“Award” means, individually or collectively, a grant under this Plan of Nonqualified Stock Options, Incentive Stock Options, SARs, Restricted Stock, Restricted Stock Units, Performance Units, or Other Stock-Based Awards, in each case subject to the terms of this Plan.
2.4“Award Agreement” means either (a) a written agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Award granted under this Plan, or (b) a written or electronic statement issued by the Company to a Participant describing the terms and provisions of such Award, including any amendment or modification thereof. The Committee may provide
Linde plc | Appendix 3-3
Appendix 3: 2021 Linde plc Long Term Incentive Plan
for the use of electronic, Internet or other non-paper Award Agreements, and the use of electronic, Internet or other non-paper means for the acceptance thereof and actions thereunder by a Participant.
2.5“Beneficial Owner” or “Beneficial Ownership” shall have the meaning ascribed to such term in Rule 13d-3 of the General Rules and Regulations under the Exchange Act.
2.6“Board” means the Board of Directors of the Company.
2.7“Change in Control” means the occurrence of any one of the following events with respect to the Company:
|
(a)
|
individuals who, on January 1, 2021, constitute the Board (the “Incumbent Directors”) cease, for any reason, to constitute at least a majority of the Board, provided that any person becoming a director subsequent to January 1, 2021, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the Company proxy statement in which such person is named as a nominee for director, without objection to such nomination) shall be an Incumbent Director; provided, however, that no individual elected or nominated as a director of the Company initially as a result of an actual or threatened election contest with respect to directors or any other actual or threatened solicitation of proxies or consents by or on behalf of any person other than the Board shall be deemed an Incumbent Director;
|
|
(b)
|
any “person” (as such term is defined in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act) is or becomes a Beneficial Owner, directly or indirectly, of securities of the Company representing 20% or more of the combined voting power of the Company’s then outstanding securities eligible to vote for the election of the Board (the “Linde Voting Securities”); provided, however, that the event described in this Subsection 2.7(b) shall not be deemed to be a Change in Control by virtue of any of the following acquisitions: (A) by the Company or any of its subsidiaries; (B) by any employee benefit plan sponsored or maintained by the Company or any of its subsidiaries; (C) by any underwriter temporarily holding securities pursuant to an offering of such securities; or (D) pursuant to a Non-Qualifying Transaction (as defined in Subsection 2.7(c));
|
|
(c)
|
the consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction involving the Company or any of its subsidiaries that requires the approval of the Company’s shareholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), unless immediately following such Business Combination: (A) more than 50% of the total voting power of (x) the corporation resulting from such Business Combination (the “Surviving Corporation”), or (y) if applicable, the ultimate parent corporation that directly or indirectly has Beneficial Ownership of 100% of the voting securities eligible to elect directors of the Surviving Corporation (the “Parent Corporation”), is represented by Linde Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, shares into which such Linde Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportion as the voting power of such Linde Voting Securities among the holders thereof immediately prior to the Business Combination, (B) no person (other than any employee benefit plan sponsored or maintained by the Surviving Corporation or the Parent Corporation), is or becomes the Beneficial Owner, directly or indirectly, of 20% or more of the total voting power of the outstanding voting securities eligible to elect directors of the Parent Corporation (or, if there is
|
Linde plc | Appendix 3-4
Appendix 3: 2021 Linde plc Long Term Incentive Plan
|
|
no Parent Corporation, the Surviving Corporation) and (C) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) were Incumbent Directors at the time of the Board’s approval of the execution of the initial agreement providing for such Business Combination (any Business Combination which satisfies all of the criteria specified in (A), (B) and (C) above shall be deemed to be a “Non-Qualifying Transaction”); or
|
|
(d)
|
the shareholders of the Company approve a plan of complete liquidation or dissolution of the Company or a sale or disposition of all or substantially all of the Company’s assets.
|
Notwithstanding the foregoing, to the extent an Award is subject to Code Section 409A, the Committee shall have the discretion to define Change in Control for such Award in a manner which complies with such Code Section.
2.8“Code” means the U.S. Internal Revenue Code of 1986, as amended from time to time. For purposes of this Plan, references to sections of the Code shall be deemed to include references to any applicable regulations thereunder and any successor or similar provision.
2.9“Committee” means, with respect to Awards granted to (a) Employees, the Compensation Committee of the Board, and (b) Directors, the Nominations and Governance Committee of the Board, and in each case, any other committee designated by the Board to administer this Plan with respect to Employee or Director Awards. The Committee shall consist of not less than two directors. However, if a member of the Committee is not a “non-employee director” within the meaning of Rule 16b-3 under the Exchange Act, the Committee may, from time to time, delegate some or all of its functions under the Plan to a committee or subcommittee composed of members that meet the relevant requirements. The term “Committee” includes any such committee or subcommittee, to the extent of the Compensation Committee’s delegation, or the Nominations and Governance Committee’s delegation, as the case may be. If the Committee does not exist or cannot function for any reason, the Board may take any action under the Plan that would otherwise be the responsibility of the Committee, other than any actions required to be carried out by a committee of at least two “non-employee directors”.
2.10“Company” means Linde plc, an Irish public limited company, and any successor thereto as provided in Article 19 herein.
2.11 “Director” means any director of the Company who is not an Employee.
2.12“Effective Date” has the meaning set forth in Section 1.1.
2.13“Employee” means any individual performing services for the Company or a Subsidiary and designated as an employee of the Company or its Subsidiaries on the payroll records thereof. An Employee shall not include any individual during any period he or she is classified or treated by the Company or its Subsidiary as an independent contractor, a consultant, or any employee of an employment, consulting, or temporary agency or any other entity other than the Company or its Subsidiary, without regard to whether such individual is subsequently determined to have been, or is subsequently retroactively reclassified as a common-law employee of the Company or its Subsidiary during such period.
2.14“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.
2.15“Fair Market Value” or “FMV” means, in respect of any date on or as of which a determination thereof is being or to be made, the closing market price of a Share reported on the New York Stock Exchange Composite Transactions tape on such date, or, if no Shares were traded on such date, on
Linde plc | Appendix 3-5
Appendix 3: 2021 Linde plc Long Term Incentive Plan
the next preceding day on which sales of Shares were reported on the New York Stock Exchange Composite Transactions tape.
2.16“Grant Date” means the date an Award is granted to a Participant pursuant to the Plan.
2.17“Grant Price” means the price established at the time of grant of a SAR pursuant to Article 7, used to determine whether there is any payment due upon exercise of the SAR.
2.18“Incentive Stock Option” or “ISO” means an Option to purchase Shares granted under Article 6 to an Employee that is designated as an Incentive Stock Option and that is intended to meet the requirements of Code Section 422, or any successor provision.
2.19“Insider” shall mean an individual who is, on the relevant date, an executive officer of the Company or a more than ten percent (10%) Beneficial Owner of any class of the Company’s equity securities that is registered pursuant to Section 12 of the Exchange Act, as determined by the Board in accordance with Section 16 of the Exchange Act.
2.20“Market Price” means, in respect of any date on or as of which a determination thereof is being or to be made, the average of the high and low prices of a Share reported on the New York Stock Exchange Composite Transactions tape on such date, or, if no Shares were traded on such date, on the next preceding day on which sales of Shares were reported on the New York Stock Exchange Composite Transactions tape.
2.21“Nonqualified Stock Option” or “NQSO” means an Option that is not intended to meet the requirements of Code Section 422, or that otherwise does not meet such requirements.
2.22“Officer” means an Employee who is either (a) an “executive officer” (within the meaning of Rule 3b-7 of the Exchange Act), or (b) an “officer” elected by the Board and holding a position with a Linde Global Grade of 30 or higher (or the future equivalent thereof).
2.23“Option” means an Incentive Stock Option or a Nonqualified Stock Option, as described in Article 6.
2.24“Option Price” means the price at which a Share may be purchased by a Participant pursuant to an Option.
2.25“Other Stock-Based Award” means an equity-based or equity-related Award not otherwise described by the terms of this Plan, granted pursuant to Article 10.
2.26“Participant” means any Employee or a Director to whom an Award is granted.
2.27“Performance Goal” means, with respect to any applicable Award to an Employee, the one or more targets, goals or levels of attainment required to be achieved in terms of the specified Performance Measures during the specified Performance Period, as set forth in the related Award Agreement.
2.28“Performance Measure” means with respect to any Award granted under Article 12 below, any performance measure or measures as determined by the Committee in its discretion and set forth in the applicable Award Agreement for purposes of determining the applicable Performance Goal.
2.29“Performance Period” means the period of time during which the Performance Goals must be met in order to determine the degree of payout and/or vesting with respect to an Award granted to an Employee.
Linde plc | Appendix 3-6
Appendix 3: 2021 Linde plc Long Term Incentive Plan
2.30“Performance Unit” means an Award to an Employee under Article 9 herein and subject to the terms of this Plan, denominated in Units, the value of which at the time it is payable is determined as a function of the extent to which corresponding Performance Goal(s) has been achieved during the applicable Performance Period.
2.31“Plan” means this 2021 Linde plc Long Term Incentive Plan.
2.32“Restricted Stock” means Shares issued pursuant to a Restricted Stock Grant under Article 8, so long as the Shares remain subject to the restrictions and conditions specified in the Award Agreement pursuant to which such Restricted Stock Grant is made.
2.33“Restricted Stock Grant” means an Award of Restricted Stock or Restricted Stock Units made pursuant to the provisions of Article 8.
2.34“Restricted Stock Unit” means a Unit issued pursuant to a Restricted Stock Grant under Article 8 so long as the Units remain subject to the restrictions and conditions specified in the Award Agreement.
2.35“Restriction Period” means the period when Restricted Stock or Restricted Stock Units are subject to a substantial risk of forfeiture (based on the passage of time, the achievement of Performance Goals, or upon the occurrence of other events as determined by the Committee, in its discretion), as provided in Article 8.
2.36“Share” means an ordinary share of EUR0.001 in the capital of the Company or any security issued by the Company in substitution or exchange therefor or in lieu thereof.
2.37“Share Equivalent” means a Unit (or fraction thereof, if authorized by the Committee) substantially equivalent to a hypothetical Share, credited to the Participant and having a value at any time equal to the FMV of a Share (or fraction thereof) at such time.
2.38“Stock Appreciation Right” or “SAR” means an Award, designated as a SAR, pursuant to the terms of Article 7 herein.
2.39“Subsidiary” means any corporation or other entity, whether domestic or foreign, in which the Company has or obtains, directly or indirectly, a proprietary interest of fifty percent (50%) or greater by reason of stock ownership or otherwise; provided, however, that (a) for purposes of determining whether any Employee can be a Participant with respect to any Award of Incentive Stock Option, the term “Subsidiary” has the meaning given to such term in Code Section 424, as interpreted by the regulations thereunder and applicable law; and (b) for purposes of determining whether any individual may be a Participant with respect to any Award of Options or SARs that are intended to be exempt from Code Section 409A, the term “Subsidiary” means any corporation or other entity to which the Company is an “eligible issuer of service recipient stock” within the meaning of Code Section 409A.
2.40“Unit” means a bookkeeping entry used by the Company to record and account for the grant or settlement of an Award until such time as the Award is paid, canceled, forfeited or terminated, as the case may be, which, except as otherwise specified by the Committee, shall be equal to one Share Equivalent.
Article 3.
|
Administration
|
3.1General. The Committee shall be responsible for administering this Plan, subject to this Article 3 and the other provisions of this Plan. The Committee may employ attorneys, consultants, accountants, agents, and other individuals, any of whom may be an Employee, and the Committee, the Company, and its officers and Directors shall be entitled to rely upon the advice, opinions, or valuations of
Linde plc | Appendix 3-7
Appendix 3: 2021 Linde plc Long Term Incentive Plan
any such individuals. All actions taken and all interpretations and determinations made by the Committee shall be final and binding upon the Participants, the Company, and all other interested individuals.
3.2Authority of the Committee. The Committee shall have sole and absolute discretionary power to interpret the terms and the intent of this Plan and any Award Agreement or other agreement or document ancillary to, or in connection with, this Plan, to determine eligibility for Awards and to adopt such rules, regulations, forms, instruments, and guidelines for administering this Plan as the Committee may deem necessary or proper and references herein to the Committee’s discretion shall refer to such sole and absolute discretion. Such authority shall include, but not be limited to, (a) selecting Participants, (b) establishing all Award terms and conditions, including the terms and conditions set forth in Award Agreements, (c) granting Awards as an alternative to or as the form of payment for grants or rights earned or due under compensation plans or arrangements of the Company, (d) construing any ambiguous provision of the Plan or any Award Agreement, (e) determining whether, to what extent and under what circumstances and method or methods (1) Awards may be (A) settled in cash, Shares, other securities, other Awards or other property, (B) exercised or (C) canceled, forfeited or suspended, (2) Shares, other securities, other Awards or other property, and other amounts payable with respect to an Award may be deferred either automatically or at the election of the Participant thereof or of the Committee, and (3) Awards may be settled by the Company or any of its designees, and (f) subject to Article 17 adopting modifications and amendments to this Plan or any Award Agreement, including, without limitation, any that are necessary to comply with the laws, rules or regulations of the countries and other jurisdictions in which the Company and/or its Subsidiaries operate or to accelerate the time or times at which the Award becomes vested, unrestricted or may be exercised. Such provisions shall be determined in the discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all such Awards, and may reflect distinctions based on the reasons for termination.
3.3Delegation. The Committee may delegate to one or more of its members or to one or more officers of the Company, and/or its Subsidiaries or to one or more agents or advisors, such administrative duties or powers as it may deem advisable, and the Committee or any individuals to whom it has delegated duties or powers as aforesaid may employ one or more individuals to render advice with respect to any responsibility the Committee or such individuals may have under this Plan. The Committee may, by resolution, authorize the Chief Executive Officer of the Company (the “CEO”) or any other officer of the Company, to do one or both of the following on the same basis as can the Committee: (a) designate Employees to be recipients of Awards and (b) determine the size of any such Awards; provided, however, (i) the Committee shall not delegate such responsibilities for any Awards to be granted to an Employee who is considered an Insider; (ii) the resolution providing such authorization sets forth the total number of Awards the CEO or officer may grant; and (iii) the CEO or officer, as applicable, shall report periodically to the Committee regarding the nature and scope of the Awards granted pursuant to the authority delegated.
3.4Non-Uniform Determinations. The Board’s and the Committee’s determinations under the Plan and Award Agreements need not be uniform and any such determinations may be made by it selectively among persons who receive, or are eligible to receive, Awards under the Plan (whether or not such persons are similarly situated). Without limiting the generality of the foregoing, the Board and the Committee will be entitled, among other things, to make non-uniform and selective determinations under Award Agreements, and to enter into non-uniform and selective Award Agreements, as to (a) the persons to receive Awards, (b) the terms and provisions of Awards and (c) whether an Award holder’s employment or other service has been terminated for purposes of the Plan.
3.5Indemnification. No member of the Committee or any person to whom administrative duties or powers have been delegated in accordance with Section 3.3 (each, an “Administrator”) will have any liability to any person (including any Participant) for any action taken or omitted or any determination made in good faith with respect to the Plan or any Award. Each Administrator will be indemnified and held harmless by the Company against and from any loss, cost, liability or expense (including attorneys’ fees) that may be imposed upon or incurred by such Administrator in connection with or resulting from any action, suit or proceeding to which such Administrator may be a party or in which such Administrator may be involved by reason of any action taken or omitted to be taken under the Plan or any Award Agreement and against and from any and all amounts paid by such
Linde plc | Appendix 3-8
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Administrator, with the Company’s approval, in settlement thereof, or paid by such Administrator in satisfaction of any judgment in any such action, suit or proceeding against such Administrator, provided that the Company will have the right, at its own expense, to assume and defend any such action, suit or proceeding and, once the Company gives notice of its intent to assume the defense, the Company will have sole control over such defense with counsel of the Company’s choice. To the extent any taxable expense reimbursement under this paragraph is subject to Section 409A of the Code, (a) the amount thereof eligible in one taxable year shall not affect the amount eligible in any other taxable year; (b) in no event shall any expenses be reimbursed after the last day of the taxable year following the taxable year in which the Administrator incurred such expenses; and (c) in no event shall any right to reimbursement be subject to liquidation or exchange for another benefit. The foregoing right of indemnification will not be available to an Administrator to the extent that a court of competent jurisdiction in a final judgment or other final adjudication, in either case, not subject to further appeal, determines that the acts or omissions of such Administrator giving rise to the indemnification claim resulted from such Administrator’s bad faith, fraud or willful misconduct. The foregoing right of indemnification will not be exclusive of any other rights of indemnification to which an Administrator may be entitled under the Company’s articles of association or constitution, as a matter of law, or otherwise, or any other power that the Company may have to indemnify such persons or hold them harmless.
Article 4.
|
Shares Subject to this Plan and Maximum Awards
|
4.1Number of Shares Available for Awards. Subject to adjustment as provided in Section 4.5, the maximum number of Shares which may be issued pursuant to Awards under this Plan on or after the Effective Date shall be 9,000,000 Shares (the “Share Authorization”). The Shares available for issuance under this Plan may be authorized and unissued Shares or treasury Shares. The maximum number of Shares of the Share Authorization that may be issued pursuant to ISOs under this Plan shall be 9,000,000 Shares. The maximum number of Shares of the Share Authorization that may be issued under this Plan pursuant to Awards other than Options or SARs shall be 3,000,000 Shares. For the avoidance of doubt, as of the Effective Date, no new awards shall be granted or awarded under the Legacy Plan and any authorized Shares that remain available for grant under new awards under the Legacy Plan shall be cancelled. Any awards granted under the Legacy Plan (whether vested or unvested) prior to the Effective Date shall remain outstanding under such plan in accordance with their terms and this Plan shall not affect the terms or conditions of any such award.
4.2Share Usage. Shares subject to an Award that expires according to its terms or is forfeited, terminated, canceled or surrendered, in each case, without having been exercised or settled, or can be paid only in cash, will be available again for grant under the Plan, without reducing the number of Shares that are available for Awards under the Plan. In no event shall (a) any Shares subject to an Option that is cancelled upon the exercise of a tandem SAR, (b) any Shares subject to an Award that are surrendered in payment of the exercise price of an Option or in payment of the taxes associated with an Award, (c) any Shares subject to a SAR that are not issued in connection with the stock settlement of the SAR upon exercise thereof, or (d) any Shares repurchased by the Company using Option proceeds, become available for grant under the Plan pursuant to this Section 4.2. Shares subject to awards that are assumed, converted or substituted under the Plan as a result of the Company’s acquisition of another company (including by way of merger, combination or similar transaction) (“Acquisition Awards”) will not count against the Share Authorization. Available shares under a shareholder approved plan of an acquired company (as appropriately adjusted to reflect the transaction) may be used for Awards under the Plan and do not reduce the Share Authorization, subject to applicable stock exchange requirements.
4.3Annual Award Limits. The following limits (each an “Annual Award Limit” and, collectively, “Annual Award Limits”), as adjusted pursuant to Section 4.5, shall apply to grants of Awards to Employees under this Plan:
|
(a)
|
Options and SARS: The maximum aggregate number of Shares subject to Options, SARs or any combination thereof granted in any one calendar year to any
|
Linde plc | Appendix 3-9
Appendix 3: 2021 Linde plc Long Term Incentive Plan
|
|
one Participant shall be 2,000,000 (with tandem Options and SARs being counted only once with respect to this limit).
|
|
(b)
|
Other Awards: The maximum aggregate number of Shares subject to Awards of Restricted Stock, Restricted Stock Units, Performance Units or Other Stock-Based Compensation granted in any one calendar year to any one Participant shall be 300,000 Shares or, in the event such Award is payable in cash, the equivalent cash value thereof on the first day of the performance period to which such Award relates, as determined by the Committee.
|
4.4Director Awards. In order to retain and compensate Directors for their services, and to strengthen the alignment of their interests with those of the shareholders of the Company, the Plan permits the grant of Awards to Directors.
4.5Adjustments in Authorized Shares. In the event of any corporate event or transaction such as a merger, consolidation, reorganization, recapitalization, separation, partial or complete liquidation, share dividend (bonus issue), other distribution of cash or property (other than normal cash dividends) to shareholders of the Company, share split, reverse share split, split up, spin-off, combination of Shares, exchange of Shares, dividend in kind, or other like change in capital structure affecting the number or type of outstanding Shares, the Committee, in order to prevent dilution or enlargement of Participants’ rights under this Plan, shall substitute or adjust, as applicable, the number and kind of Shares that may be issued under this Plan or under particular forms of Awards, the number and kind of Shares subject to outstanding Awards (including, without limitation, the substitution of other securities, cash or property in lieu thereof), the Option Price or Grant Price applicable to outstanding Awards, the Annual Award Limits, and other value determinations applicable to outstanding Awards.
To further reflect any of the foregoing events, transactions or adjustments, the Committee, in its discretion, may also make adjustments in the terms of any Awards under this Plan and may modify any other terms of outstanding Awards, including modifications of Performance Goals and changes in the length of Performance Periods, as it deems necessary or appropriate. The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on Participants under this Plan.
Subject to the provisions of Article 16 and notwithstanding anything else herein to the contrary, without affecting the number of Shares reserved or available hereunder, the Committee may authorize the issuance or assumption of benefits under this Plan in connection with any merger, consolidation, acquisition of property or stock, or reorganization upon such terms and conditions as it may deem appropriate (including, but not limited to, a conversion of equity awards into Awards under this Plan in a manner consistent with FASB ASC Topic 718).
Article 5.
|
Eligibility and Participation
|
Only Employees and Directors shall be eligible to participate in this Plan. Subject to the provisions of this Plan, the Committee may, from time to time, select those Employees or Directors to whom Awards shall be granted and shall determine, in its discretion, the nature of, any and all terms permissible by law, and the amount of each Award; provided, however, that no Award made to a Director shall be subject to or conditioned upon the attainment of any Performance Goal.
6.1Grant of Options. Subject to the terms and provisions of this Plan, Options may be granted to Participants in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee, in its discretion. Options may be granted in addition to, or in tandem with or independent of, SARs or any other Awards under the Plan.
Linde plc | Appendix 3-10
Appendix 3: 2021 Linde plc Long Term Incentive Plan
6.2Award Agreement. Each Option grant shall be evidenced by an Award Agreement that shall specify the Option Price, the term of the Option, the number of Shares to which the Option pertains, the conditions, including any Performance Goals, upon which an Option shall become vested and exercisable, and such other terms and conditions as the Committee shall determine which are not inconsistent with the terms of this Plan. The Award Agreement also shall specify whether the Option is intended to be an ISO or an NQSO. To the extent that an Award Agreement does not specify whether the Option is intended to be an ISO or an NQSO, such Option shall be an NQSO.
6.3Option Price. The Option Price for each grant of an Option under this Plan shall be determined by the Committee in its discretion and shall be specified in the Award Agreement; provided, however, the Option Price (other than the Option Price of Acquisition Awards) must be at least equal to 100% of the FMV of the Shares as determined on the Grant Date.
6.4Term of Options. Each Option granted to a Participant shall expire at such time as the Committee shall determine at the time of grant; provided, however, no Option shall be exercisable later than the day before the tenth (10th) anniversary of its Grant Date.
6.5Exercise of Options. Options shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant. Except upon a Change in Control and in certain limited situations (including, but not limited to, the death or disability of the Participant): (a) Awards of Options subject solely to the continued service of the Participant shall become exercisable no earlier than three (3) years after the Grant Date, provided that such Option may partially vest after no less than one (1) year following such Grant Date; and (b) any other Award of Options shall become exercisable no earlier than one (1) year after the Grant Date.
6.6Payment. Options shall be exercised by the delivery of a notice of exercise to the Company or an agent designated by the Company in a form specified or accepted by the Committee, or by complying with any alternative procedures which may be authorized by the Committee, setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full payment for the Shares.
A condition of the issuance of the Shares as to which an Option shall be exercised shall be the payment of the Option Price. The Option Price of any Option shall be payable to the Company in full either: (a) in cash or its equivalent; (b) by tendering (either by actual delivery or attestation) previously acquired Shares having an aggregate Market Price at the time of exercise equal to the Option Price (provided that the Shares that are tendered may be subject to a minimum holding period, as determined by the Committee in its discretion, prior to their tender to satisfy the Option Price if acquired under this Plan or any other compensation plan maintained by the Company or have been purchased on the open market); (c) by having the Company withhold Shares that otherwise would be delivered to the exerciser pursuant to the exercise of the Option having a value equaling the aggregate Option Price due; (d) by a cashless (broker-assisted) exercise; (e) by a combination of (a), (b), (c) and/or (d); or (f) any other method approved or accepted by the Committee in its discretion.
Subject to any governing rules or regulations, as soon as practicable after receipt of written notification of exercise and full payment (including satisfaction of any applicable tax withholding), the Company shall deliver to the Participant evidence of book entry Shares.
Unless otherwise determined by the Committee, all payments under all of the methods indicated above shall be paid in United States dollars.
6.7Notification of Disqualifying Disposition. If any Participant shall make any disposition of Shares issued pursuant to the exercise of an ISO under the circumstances described in Code Section 421(b) (relating to certain disqualifying dispositions), such Participant shall notify the Company of such disposition within ten (10) days thereof.
Linde plc | Appendix 3-11
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Article 7.
|
Stock Appreciation Rights
|
7.1Grant of SARs. Subject to the terms and conditions of this Plan, SARs may be granted to Participants at any time and from time to time as shall be determined by the Committee, in its discretion. Subject to the terms and conditions of this Plan, the Committee shall have discretion in determining the number of SARs granted to each Participant and, consistent with the provisions of this Plan, in determining the terms and conditions pertaining to such SARs. SARs may be granted under the Plan alone, in tandem with, in addition to or independent of, Options or any other Awards under the Plan.
7.2SAR Agreement. Each SAR Award shall be evidenced by an Award Agreement that shall specify the Grant Price, the term of the SAR, the number of Shares to which the SAR pertains, the conditions, including any Performance Goals, upon which the SAR shall become vested and exercisable, and such other terms and conditions as the Committee shall determine, which are not inconsistent with the terms of this Plan.
7.3Term of SAR. The term of a SAR granted under this Plan shall be determined by the Committee, in its discretion, and specified in the SAR Award Agreement; provided, however, no SAR shall be exercisable later than the tenth (10th) anniversary of its Grant Date.
7.4Grant Price. The Grant Price for each Award of a SAR shall be determined by the Committee and shall be specified in the Award Agreement; provided, however, the Grant Price must be at least equal to 100% of the FMV of the Shares as determined on the Grant Date (other than the Grant Price of Acquisition Awards).
7.5Exercise of SARs. SARs shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant. Except upon a Change in Control and in certain limited situations (including, but not limited to, the death or disability of the Participant): (a) Awards of SARs subject solely to the continued service of the Participant shall become exercisable no earlier than three (3) years after the Grant Date provided that such SAR may partially vest after no less than one (1) year following such Grant Date; and (b) any other Award of SARs shall become exercisable no earlier than one (1) year after the Grant Date. The Committee may provide that a SAR shall be automatically exercised on one or more specified dates.
7.6Payment of SARs. Upon the exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount determined by multiplying:
|
(a)
|
The excess of the FMV of a Share on the date of exercise over the Grant Price; by
|
|
(b)
|
The number of Shares with respect to which the SAR is exercised.
|
At the discretion of the Committee, the payment upon exercise of a SAR may be in cash, Shares, or any combination thereof, or in any other manner approved by the Committee in its discretion. The Committee’s determination regarding the form of SAR payout shall be set forth in the Award Agreement pertaining to the grant of the SAR.
Article 8.
|
Restricted Stock Grants
|
8.1Grant of Restricted Stock or Restricted Stock Units. Subject to the terms and provisions of this Plan, the Committee, at any time and from time to time, may grant Restricted Stock Grants to Participants in such amounts as the Committee shall determine. A Restricted Stock Grant is the issue of Shares or Units in the name of a Participant subject to such terms and conditions as the Committee shall deem appropriate, including, without limitation, restrictions on the sale, assignment, transfer or other disposition of such Shares or Units and the requirement that the Participant forfeit such Shares or Units back to the Company (a) upon termination of employment of an Employee or termination of service as a
Linde plc | Appendix 3-12
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Director for specified reasons within a specified period of time; (b) if any specified Performance Goals are not achieved during a specified Performance Period; or (c) if such other conditions as the Committee may specify are not satisfied.
8.2Restricted Stock or Restricted Stock Unit Agreement. Each Restricted Stock Grant shall be evidenced by an Award Agreement that shall specify the Restriction Period(s), the number of Shares of Restricted Stock and/or Restricted Stock Units granted, the conditions and restrictions imposed upon the Restricted Stock Grant, and such other provisions as the Committee shall determine which are not inconsistent with the terms of this Plan.
8.3Restriction Period. Each Restricted Stock Grant shall provide that in order for a Participant to receive unrestricted Shares or payment in settlement of a Restricted Stock Unit, the Participant must remain an Employee or a Director, as the case may be, for a period of time specified by the Committee in the Award Agreement. The Committee may also establish one or more Performance Goals that are required to be achieved during one or more Performance Periods within the Restriction Period as a condition to the lapse of restrictions of Awards to Employees. Except upon a Change in Control and in certain limited situations (including, but not limited to, the death or disability of the Participant): (a) Awards of Restricted Stock and/or Restricted Stock Units subject solely to the continued service of the Participant shall have a Restriction Period of not less than three (3) years from the Grant Date; provided, however, that up to an aggregate of five percent (5%) of the 3,000,000 Share Authorization under Section 4.1 of this Plan applicable to Awards other than Options or SARs, as may be adjusted from time to time pursuant to the provisions of this Plan, may be granted to Participants with a vesting period of less than three (3) years; and (b) Awards to Employees of Restricted Stock and/or Restricted Stock Units subject to the achievement of one or more Performance Goals shall have a minimum Restriction Period of one (1) year. The Committee may provide for the lapse of restrictions in installments during the Restriction Period.
8.4Restrictions. During the Restriction Period, the Participant may not sell, assign, transfer, pledge, hypothecate, encumber or otherwise dispose of or realize on the Shares or Units subject to the Restricted Stock Grant. Unless otherwise directed by the Committee, (i) all certificates representing Shares of Restricted Stock will be held in custody by the Company until all restrictions thereon have lapsed, together with a stock power or powers executed by the Participant in whose name such certificates are registered, endorsed in blank and covering such Shares, or (ii) all uncertificated Shares of Restricted Stock will be held at the Company’s transfer agent in book entry form with appropriate restrictions relating to the transfer of such Shares of Restricted Stock. The Committee may, in its discretion, include such other restrictions and conditions as it may deem appropriate.
8.5Payment. Subject to Section 12.4 below, if applicable, upon expiration of the Restriction Period and if all conditions have been satisfied and any applicable Performance Goals attained, the Shares of Restricted Stock will be made available to the Participant or the Restricted Stock Units will be vested in the account of the Participant, free of all restrictions, provided that the Committee may, in its discretion, require (a) the further deferral of any Restricted Stock Grant beyond the initially specified Restriction Period; (b) that the Restricted Stock or Restricted Stock Units be retained by the Company; and (c) that the Participant receive a cash payment in lieu of unrestricted Shares or Units.
8.6Rights as a Shareholder. Unless otherwise determined by the Committee and set forth in a Participant’s Award Agreement, the Participant shall have, with respect to shares of Restricted Stock, all of the rights of a shareholder of the Company, including the right to vote the shares and receive any dividends paid thereon. Any such dividends shall be reinvested on the dividend payment date in additional Shares of Restricted Stock under the Restricted Stock Grant and shall be subject to the restrictions and other terms and conditions set forth therein. A Participant shall not have, with respect to Restricted Stock Units, any voting or other rights of a shareholder of the Company; provided, however, that if determined by the Committee and set forth in the Participant’s Award Agreement, the Participant shall have the right to receive Dividend Equivalents in accordance with the provisions of Article 13.
8.7Section 83(b) Election. The Committee may provide in an Award Agreement that the Award of Restricted Stock is conditioned upon the Participant making or refraining from making an election
Linde plc | Appendix 3-13
Appendix 3: 2021 Linde plc Long Term Incentive Plan
with respect to the Award under Code Section 83(b). If a Participant makes an election pursuant to Code Section 83(b) concerning a Restricted Stock Award, the Participant shall be required to file promptly a copy of such election with the Company.
8.8Restricted Stock Grants Subject to Performance-Based Vesting. Restricted Stock Grant that are subject to performance-based vesting shall also be subject to the terms and conditions of Article 12 below.
Article 9.
|
Performance Units
|
9.1Grant of Performance Units. Subject to the terms and provisions of this Plan, the Committee, at any time and from time to time, may grant Performance Units to Employees in such amounts and upon such terms as the Committee shall determine. Each Performance Unit shall represent the prospective contingent right to receive payment based upon Company and/or Subsidiary performance over a specified Performance Period. Each Performance Unit shall have an initial value that is established by the Committee at the time of grant and need not be equivalent to the value of a Share Equivalent. At the time of grant, the Committee, in its discretion, shall establish the Performance Period, Performance Measures, Performance Goals and such other terms and conditions applicable to such Award. The number of Shares and/or the amount of cash or other consideration earned in settlement of a Performance Unit shall be determined at the end of the Performance Period.
9.2Earning of Performance Units. Each Performance Unit Award Agreement shall provide that in order for an Employee to receive a payment in settlement of the Award, the Company must achieve certain Performance Goals over a designated Performance Period, with attainment of one or more Performance Goals determined using one or more specific Performance Measures. The Performance Goals and the Performance Period shall be established by the Committee in its discretion; provided, however, that except upon a Change in Control and in certain limited situations (including, but not limited to, the death or disability of the Participant), the Performance Period must have a minimum duration of one (1) year. The Committee shall establish one or more Performance Measures for each Performance Period for determining the portion of the Performance Unit Award, which will be earned or forfeited, based on the extent to which the Performance Goals are achieved or exceeded. Such Performance Goals may include minimum, maximum and target levels of performance, with the size of the payment payable in settlement of the Performance Unit Award based on the level attained.
9.3Form of Performance Unit Award. Performance Unit Awards shall be made on such terms and conditions not inconsistent with the Plan, and in such form or forms, as the Committee may, from time to time, approve. Performance Units may be awarded alone, in addition to, or independent of other Awards under the Plan. Subject to the terms of the Plan, the Committee shall, in its discretion, determine the number of Units subject to each Performance Unit Award made to an Employee and may impose different terms and conditions on any particular Performance Unit Award made to any Employee. The Performance Goals, Performance Period or Periods, Performance Measures and other terms and conditions applicable to any Performance Unit Award shall be set forth in the relevant Award Agreement.
9.4Payment of Performance Units. Subject to the terms of this Plan and the applicable Award Agreement, after the later of the date the applicable Performance Period has ended or the date on which any other terms and conditions applicable to such Performance Unit Award have been satisfied, the holder of Performance Units shall be entitled to receive payout of the value and number of Performance Units earned by the Employee over the Performance Period, to be determined as a function of the extent to which the corresponding Performance Goals have been achieved. Subject to Section 12.4 below, if applicable, such payment shall be as determined by the Committee and as evidenced in the Award Agreement. Subject to the terms of this Plan, the Committee, in its discretion, may pay earned Performance Units in the form of Shares, cash, any combination thereof, or any other form as designated by the Committee in its discretion, equal to the value of the earned Performance Units at the close of the applicable Performance Period, or at such other time as specified in the Award Agreement. Any Shares paid in settlement of such Performance Units may be granted subject to any restrictions deemed appropriate by
Linde plc | Appendix 3-14
Appendix 3: 2021 Linde plc Long Term Incentive Plan
the Committee. The determination of the Committee with respect to the form of payout of such Awards shall be set forth in the applicable Award Agreement.
Article 10.
|
Other Stock-Based Awards
|
10.1Other Stock-Based Awards. The Committee may grant other types of equity-based or equity-related Awards not otherwise described by the terms of this Plan (including, subject to the limitations below, the grant or offer for sale of unrestricted Shares) in such amounts and subject to such terms and conditions, as the Committee shall determine. Such Awards may involve the transfer of actual Shares to Participants, or payment in cash or otherwise of amounts based on the value of Shares and may include, without limitation, Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States. Notwithstanding any provision in this Plan to the contrary, Awards of unrestricted Shares shall only be made in lieu of salary and/or cash bonuses/variable compensation paid to Employees or cash fees paid to Directors.
10.2Value of Other Stock-Based Awards. Each Other Stock-Based Award shall be expressed in terms of Shares or Units, as determined by the Committee. The Committee may, in its discretion, establish Performance Goals with respect to any Other Stock-Based Awards. If the Committee exercises its discretion to establish Performance Goals, the number and/or value of Other Stock-Based Awards that will be paid out to the Participant may depend on the extent to which the Performance Goals are met.
10.3Payment of Other Stock-Based Awards. Payment, if any, with respect to an Other Stock-Based Award shall be made in accordance with the terms of the Award, in cash or Shares as the Committee determines.
10.4Other Stock-Based Awards Subject to Performance-Based Vesting. Any Other Stock-Based Award that is subject to performance-based vesting shall also be subject to the terms and conditions of Article 12 below.
Article 11.
|
Transferability of Awards
|
No Award under the Plan, and no right or interest therein, shall be (a) assignable, alienable, pledgable or transferable by a Participant, except by will or the laws of descent and distribution, or (b) subject to any obligation, or the lien or claims of any creditor, of any Participant, or (c) subject to any lien, encumbrance or claim of any party made in respect of or through any Participant, however arising. During the lifetime of a Participant, Options and SARs are exercisable only by, Shares issued upon the exercise of Options and SARs or in settlement of other Awards will be issued only to, and other payments in settlement of any Award will be payable only to, the Participant or his or her legal representative. Notwithstanding the foregoing, the Committee may, in its discretion and on and subject to such terms and conditions as it shall deem appropriate, which terms and conditions shall be set forth in the related Award Agreement: (i) authorize a Participant to transfer all or a portion of any Nonqualified Stock Option or SAR, as the case may be, granted to such Participant, provided that in no event shall any transfer be made to any person or persons other than such Participant’s spouse, children or grandchildren, or a trust or partnership for the exclusive benefit of one or more such persons, which transfer must be made as a gift and without any consideration; and (ii) provide for the transferability of a particular grant or Award pursuant to a domestic relations order. All other transfers and any retransfer by any permitted transferee are prohibited and any such purported transfer shall be null and void. Each Nonqualified Stock Option or SAR which becomes the subject of a permitted transfer (and the Participant to whom it was granted by the Company) shall continue to be subject to the same terms and conditions as were in effect immediately prior to such permitted transfer. The Participant shall remain responsible to the Company for the payment of all withholding taxes incurred as a result of any exercise of such Option or SAR. In no event shall any permitted transfer of an Option, SAR or other grant or Award create any right in any party in respect of any Option, SAR or other grant or Award, other than the rights of the qualified transferee in respect of such Option, SAR or other Award specified in the related Award Agreement.
Linde plc | Appendix 3-15
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Article 12.
|
Performance Measures
|
12.1Performance Measures. The Performance Goals upon which the payment or vesting of an Award granted pursuant to this Article 12 may be one or more of the Performance Measures determined by the Committee in its discretion.
Any Performance Measure or Measures may be used to measure the performance of the Company and/or its Subsidiary as a whole or any business unit of the Company and/or its Subsidiary or any combination thereof, as the Committee may deem appropriate, or any of the above Performance Measures as compared to the performance of a group of comparator companies, or published or special index that the Committee, in its discretion, deems appropriate, or the Committee may select Share price as a Performance Measure as compared to various stock market indices. The Committee also has the authority to provide in an Award Agreement for accelerated vesting of any Award based on the achievement of Performance Goals pursuant to the applicable Performance Measures.
Except as otherwise expressly provided in the Plan or an Award Agreement, all financial terms are used as defined under Generally Accepted Accounting Principles or such other objective accounting principles, as may be designated by the Committee.
12.2Establishment of the Performance Period, Performance Goals and Formula. Except as otherwise required under applicable law, rule or regulation or the applicable Award Agreement, a Participant’s Award that is granted pursuant to this Article 12 shall be determined based on the attainment of the applicable Performance Goals approved by the Committee for a Performance Period established by the Committee.
12.3Evaluation of Performance. The Committee may determine in its discretion whether any evaluation of performance should include or exclude the effect of (a) any transaction, occurrence or other event impacting an applicable Performance Goal or Performance Measure or (b) any unforeseen market conditions beyond the control of the Company and its Subsidiaries, Employees, officers and directors.
12.4Adjustment of Performance-Based Awards. Performance Goals and/or the Performance Measures applicable to Awards that are granted pursuant to this Article 12 may be adjusted upward or downward as determined by the Committee in its discretion. The Committee shall retain the discretion to adjust such Awards either on a formula or discretionary basis or any combination, as the Committee determines.
Article 13.
|
Dividend Equivalents
|
Any Participant selected by the Committee may be granted dividend equivalents based on the dividends declared on Shares or Share Equivalents that are subject to any Award (other than Options and SARs), to be credited as of dividend payment dates, during the period between the date the Award is granted and the date the Award is exercised, vests, settled or expires, as determined by the Committee (“Dividend Equivalents”). Except as otherwise provided in the Plan or the applicable Award Agreement, such Dividend Equivalents shall be converted to cash or additional Shares or Share Equivalents by such formula, at such time and subject to such limitations as may be determined by the Committee; provided, however, that in no event shall any Dividend Equivalents become payable earlier than the date on which the underlying Award becomes vested and payable.
Article 14.
|
Termination of Employment or Service as a Director
|
14.1Stock Options and SARs. Each Award Agreement shall set forth the extent to which the Participant shall have the right to exercise an Option or SAR following termination of, as the case may be, (a) an Employee’s employment with the Company and/or its Subsidiaries or (b) a Director’s service as a director of the Company. Such provisions shall be determined in the discretion of the Committee, shall be
Linde plc | Appendix 3-16
Appendix 3: 2021 Linde plc Long Term Incentive Plan
included in the Award Agreement entered into with each Participant, need not be uniform among all Options and SARs issued under this Plan, and may reflect distinctions based on the reasons for termination.
14.2Restricted Stock Grant, Performance Units and Other Stock-Based Awards. The Award Agreement for each Restricted Stock Grant, Performance Unit and Other Stock-Based Award shall set forth the extent to which such Award shall vest and/or may be forfeited upon termination of, as the case may be, (a) the Employee’s employment with the Company and/or its Subsidiaries or (b) Director’s service as a director of the Company. Such provisions shall be determined in the discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all such Awards, and may reflect distinctions based on the reasons for termination.
Article 15.
|
Rights of Participants
|
15.1Employment. Nothing in this Plan or an Award Agreement shall interfere with or limit in any way the right of the Company and/or its Subsidiaries, to terminate any Employee’s employment at any time or for any reason not prohibited by law, nor confer upon any Employee any right to continue his employment, or upon any Director a right to continue to serve as a Director, for any specified period of time.
Neither an Award nor any benefits arising under this Plan shall constitute an employment contract with the Company and/or its Subsidiaries for an Employee or a contract for service as a director with the Company for a Director and, accordingly, subject to Article 17, this Plan and the benefits hereunder may be terminated at any time in the discretion of the Committee without giving rise to any liability on the part of the Company and/or its Subsidiaries.
15.2Participation. No individual shall have the right to be selected to receive an Award under this Plan, or, having been so selected, to be selected to receive a future Award.
15.3Rights as a Shareholder. Except as otherwise provided herein, a Participant shall have none of the rights of a shareholder with respect to Shares covered by any Award until the Participant becomes the record holder of such Shares.
Article 16.
|
Change in Control
|
The Committee, in its discretion, may specify in the applicable Award Agreement the effect, if any, of a Change in Control on any Award held by a Participant, including the adjustment or other treatment of Performance Goals; provided, however, that any such provision included in an Award Agreement granted to a Participant who is at the time an Officer shall specify that if (i) a Change in Control occurs and (ii) within two (2) years thereafter (or such other period of time following the Change in Control specified in the applicable Award Agreement), such Officer’s employment with the Company (or an applicable Subsidiary) or any successor thereto is terminated without “cause” (as defined in the applicable Award Agreement) or if the Officer terminates employment for “good reason” (as defined in the applicable Award Agreement), then such Award shall become partially or fully vested (including the lapsing of restrictions and conditions) and, as applicable, exercisable as of the date of such termination of employment.
Notwithstanding the foregoing, the Committee may, in its discretion, determine in connection with a Change in Control that any or all outstanding Awards granted under the Plan, whether or not exercisable, will be canceled and terminated and that in connection with such cancellation and termination, the holder of such Award may receive for each Share subject to such Awards a cash payment (or the delivery of shares of stock, other securities or a combination of cash, stock and securities equivalent to such cash payment) equal to the difference, if any, between the consideration received by shareholders of the Company in respect of a Share in connection with such transaction and the purchase price per share, if any, under the Award, multiplied by the number of Shares subject to such Award; provided that if such product is zero or less, the Award will be canceled and terminated without payment therefor.
Linde plc | Appendix 3-17
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Article 17.
|
Amendment, Modification, Suspension, and Termination
|
17.1Amendment, Modification, Suspension, and Termination. Subject to Section 17.2, the Board may, at any time and from time to time, alter, amend, modify, suspend, or terminate this Plan and any Award Agreement in whole or in part without approval of the Company’s shareholders, unless such approval is necessary to comply with applicable laws, including the Exchange Act and the Code, or the rules and regulations of any securities exchange on which the Shares are listed. In no event may the Board amend the Plan without the prior approval of the Company’s shareholders to (a) increase the maximum number of Shares which may be issued pursuant to the Plan; (b) increase any limitation set forth in the Plan on the number of Shares which may be issued, or the aggregate value of Awards which may be made, in respect of any type of Award to any single Participant during any specified period; (c) change the class of individuals eligible to participate in the Plan; (d) reduce the minimum Option Price or the minimum SAR Grant Price as set forth in Sections 6.3 and 7.4; or (e) reduce the minimum vesting period, Restriction Period or Performance Period requirements applicable to Awards under the Plan. Furthermore, except as provided in Section 4.5 and Article 16, in no event may the terms of a previously granted Option or SAR be amended to reduce its Option Price or Grant Price, as applicable, or to cancel the Award (including following a Participant’s voluntary surrender of an “underwater” Option or SAR) in exchange for cash or an Option, SAR, or other Award with an Option Price, Grant Price or other exercise price that is less than the Option Price or Grant Price, as applicable, of the original Option or SAR, without obtaining approval of the Company’s shareholders.
17.2Awards Previously Granted. Notwithstanding any other provision of this Plan to the contrary (other than Section 17.3), no termination, amendment, suspension, or modification of this Plan or an Award Agreement shall adversely affect in any material way any Award previously granted under this Plan, without the written consent of the Participant holding such Award.
17.3Amendment to Conform to Law. Notwithstanding any other provision of this Plan to the contrary, the Board may amend the Plan or an Award Agreement, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of conforming the Plan or an Award Agreement to any present or future law relating to plans of this or similar nature and to the administrative regulations and rulings promulgated thereunder. By accepting an Award under this Plan, a Participant agrees to any amendment made pursuant to this Section 17.3 to any Award granted under the Plan without further consideration or action.
Article 18.
|
Tax Withholding; No Liability with Respect to Tax Qualification or Adverse Tax Treatment
|
All Awards under the Plan will be made subject to any applicable withholding for taxes of any kind. The Company shall have the right to deduct from any amount payable under the Plan, including delivery of Shares to be made under the Plan, all federal, state, city, local or foreign taxes of any kind required by law to be withheld with respect to such payment and to take such other actions as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such taxes. The Company shall have the right to require a Participant to pay cash to satisfy withholding taxes as a condition to the payment of any amount (whether in cash or Shares) under the Plan.
Notwithstanding anything to the contrary contained herein, in no event shall the Company be liable to a Participant on account of an Award’s failure to (a) qualify for favorable United States or foreign tax treatment or (b) avoid adverse tax treatment under United States or foreign law, including, without limitation, Section 409A of the Code.
All obligations of the Company under this Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
Linde plc | Appendix 3-18
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Article 20.
|
General Provisions
|
20.1Forfeiture Events and Clawback. The Committee may specify in an Award Agreement that the Participant’s rights, payments, and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture, or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include, but shall not be limited to, any Participant’s fraud resulting in the restatement of the Company’s published earnings, termination of an Employee’s employment or a Director’s service as a director for cause, termination of the Participant’s provision of services to the Company and/or its Subsidiary, violation of material Company and/or Subsidiary policies, breach of noncompetition, confidentiality, or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is detrimental to the business or reputation of the Company and/or its Subsidiaries. In addition, Awards shall be subject to the clawback or recapture policy, if any, that the Company may adopt from time to time to the extent provided in such policy and, in accordance with such policy, may be subject to the requirement that the Awards be repaid to the Company after they have been distributed or paid to the Participant.
20.2Legend; Restrictions on Share Transferability; Stock Ownership Policy. The certificates or book entry for Shares may include any legend or notation, which the Committee deems appropriate to reflect any restrictions on transfer of such Shares. The Committee may impose such restrictions on any Shares acquired pursuant to an Award as it may deem advisable, including, without limitation, minimum holding period requirements, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, or under any blue sky or state or other securities laws applicable to such Shares. In addition, as applicable, each Participant shall at all times be subject to compliance with the Company’s executive stock ownership policy, as in effect from time to time, with respect to each Award.
20.3Severability. In the event any provision of this Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included.
20.4Requirements of Law. The granting of Awards and the issuance of Shares under this Plan shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.
20.5Delivery of Title. The Company shall have no obligation to issue or deliver evidence of title for Shares issued under this Plan prior to:
|
(a)
|
Obtaining any approvals from governmental agencies that the Company determines are necessary or advisable; and
|
|
(b)
|
Completion of any registration or other qualification of the Shares under any applicable national or foreign law or ruling of any governmental body that the Company determines to be necessary or advisable.
|
20.6Inability to Obtain Authority. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.
20.7Investment Representations. The Committee may require any individual receiving Shares pursuant to an Award under this Plan to represent and warrant in writing that the individual is acquiring the Shares for investment and without any present intention to sell or distribute such Shares.
20.8Employees or Directors Based Outside of the United States. Notwithstanding any provision of this Plan to the contrary, in order to comply with the laws in other countries in which the
Linde plc | Appendix 3-19
Appendix 3: 2021 Linde plc Long Term Incentive Plan
Company and/or its Subsidiaries operate or have Employees or in which Directors may reside, the Committee, in its discretion, shall have the power and authority to:
|
(a)
|
Determine which Subsidiaries shall be covered by this Plan;
|
|
(b)
|
Determine which Employees or Directors outside the United States are eligible to participate in this Plan;
|
|
(c)
|
Modify the terms and conditions of any Award granted to Employees or Directors outside the United States to comply with applicable foreign laws;
|
|
(d)
|
Establish subplans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable. Any subplans and modifications to Plan terms and procedures established under this Section 20.8 by the Committee shall be attached to this Plan document as appendices; and
|
|
(e)
|
Take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any necessary local government regulatory exemptions or approvals.
|
Notwithstanding the above, the Committee may not take any actions hereunder, and no Awards shall be granted, that would violate applicable law.
20.9Uncertificated Shares. The transfer of Shares in connection with the exercise or settlement of an Award granted hereunder may be effected on a noncertificated basis, to the extent not prohibited by applicable law or the rules of any stock exchange.
20.10Unfunded Plan. Participants shall have no right, title, or interest whatsoever in or to any investments that the Company, and/or its Subsidiaries may make to aid it in meeting its obligations under this Plan. Nothing contained in this Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative, or any other individual. To the extent that any individual acquires a right to receive payments from the Company and/or its Subsidiaries under this Plan, such right shall be no greater than the right of an unsecured general creditor of the Company or a Subsidiary, as the case may be. All payments to be made hereunder shall be paid from the general funds of the Company or a Subsidiary, as the case may be, and no special or separate fund shall be established and no segregation of assets shall be made to assure payment of such amounts except as expressly set forth in this Plan.
20.11No Fractional Shares. No fractional Shares shall be issued or delivered pursuant to this Plan or any Award. To the extent settlement or payout of an Award would result in a fractional Share being issuable, the number of Shares subject to settlement or payout under such Award shall be rounded down to the nearest whole Share and any rights to any fractional Shares (or payment therefor) shall be forfeited.
20.12Section 409A of the Code; Deferrals. The Committee shall have full authority to give effect to any statement in an Award Agreement to the effect that an Award is intended to be “deferred compensation” subject to Section 409A, to be exempt from Section 409A or to have other intended treatment under Section 409A and/or other provision of the Code. To the extent necessary to give effect to this authority, in the case of any conflict or potential inconsistency between the Plan and a provision of any Award or Award Agreement with respect to the subject matter of this Section 20.12, the Plan shall govern. With respect to any Award made under the Plan that is intended to be “deferred compensation” subject to Section 409A: (a) references to termination of the Participant’s employment will mean the Participant’s “separation from service” with the Company or any applicable Subsidiary within the meaning of Section 409A; (b) any payment to be made with respect to such Award in connection with the Participant’s separation from service with the Company or any applicable Subsidiary that would be subject to the
Linde plc | Appendix 3-20
Appendix 3: 2021 Linde plc Long Term Incentive Plan
limitations in Section 409A(a)(2)(b) of the Code shall be delayed until six months after the Participant’s separation from service (or earlier death) in accordance with the requirements of Section 409A; (c) to the extent necessary to comply with Section 409A, any cash, other securities, other Awards or other property that the Company may deliver in lieu of Shares in respect of an Award shall not have the effect of deferring delivery or payment beyond the date on which such delivery or payment would occur with respect to the Shares that would otherwise have been deliverable (unless the Committee elects a later date for this purpose in accordance with the requirements of Section 409A); (d) if the Award includes a “series of installment payments” (within the meaning of Section 1.409A-2(b)(2)(iii) of the regulations promulgated under the Code), the Participant’s right to the series of installment payments shall be treated as a right to a series of separate payments and not as a right to a single payment; and (e) if the Award includes “dividend equivalents” (within the meaning of Section 1.409A-3(e) of the regulations promulgated under the Code), the Participant’s right to the dividend equivalents shall be treated separately from the right to other amounts under the Award.
To the extent permitted by Code Section 409A, the Committee may, whether at the time of grant or at any time thereafter prior to payment or settlement, require a Participant to defer, or permit (subject to such conditions as the Committee may from time to time establish) a Participant to elect to defer, receipt of all or any portion of any payment of cash or Shares that would otherwise be due to such Participant in payment or settlement of any Award under the Plan. If any such deferral is required by the Committee (or is elected by the Participant with the permission of the Committee), the Committee shall establish rules and procedures for payment of such deferrals. The Committee may provide for the payment or crediting of interest, at such rate or rates as it shall in its discretion deem appropriate, on such deferred amounts credited in cash and the payment or crediting of Dividend Equivalents in respect of deferred amounts credited in Share Equivalents or Restricted Stock Units. Deferred amounts may be paid in a lump sum or in installments in the manner and to the extent permitted, and in accordance with rules and procedures established by the Committee. This Section 20.12 shall not apply to any grant of Options or SARs that are intended to be exempt from Code Section 409A.
20.13Nonexclusivity of this Plan. The adoption of this Plan shall not be construed as creating any limitations on the power of the Board or Committee to adopt such other compensation arrangements as it may deem desirable for any Participant or Participants.
20.14No Constraint on Corporate Action. Nothing in this Plan shall be construed to: (a) limit, impair, or otherwise affect the Company’s or a Subsidiary’s right or power to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure, or to merge or consolidate, or dissolve, liquidate, sell, or transfer all or any part of its business or assets; or (b) limit the right or power of the Company or a Subsidiary to take any action which such entity deems to be necessary or appropriate.
20.15Governing Law. The Plan and each Award Agreement shall be governed by the laws of the State of Connecticut, excluding any conflict of laws or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction. Unless otherwise provided in the Award Agreement, recipients of an Award under this Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts in Fairfield County, Connecticut, to resolve any and all issues that may arise out of or relate to this Plan or any related Award Agreement.
20.16Right of Offset. Except with respect to Awards that are intended to be “deferred compensation” subject to Section 409A, the Company will have the right to offset against its obligation to deliver Shares (or cash, other securities or other property) under the Plan or any Award Agreement any outstanding amounts (including, without limitation, travel and entertainment or advance account balances, loans, repayment obligations under any Awards, or amounts repayable to the Company pursuant to tax equalization, relocation, automobile or other employee programs) that the Participant then owes to the Company and any amounts the Committee otherwise deems appropriate pursuant to any tax equalization policy or agreement.
20.17Irish Conditions of Issuance. Notwithstanding any other provision of this Plan or any Award Agreement, (a) the Company shall not be obliged to issue any Shares pursuant to an Award unless
Linde plc | Appendix 3-21
Appendix 3: 2021 Linde plc Long Term Incentive Plan
at least the par (nominal) value of such newly issued Share has been fully paid in advance in accordance with applicable law (which requirement may mean the holder of an Award is obliged to make such payment), (b) no adjustments may be made to an Award which reduce the price payable for a Share subject to such Award below the par (nominal) value of a Share and (c) the Company shall not be obliged to issue or deliver any Shares in satisfaction of Awards until all legal and regulatory requirements associated with such issue or delivery have been complied with to the satisfaction of the Committee.
20.18No Third Party Beneficiaries. Except as expressly provided therein, neither the Plan nor any Award Agreement will confer on any person other than the Company and the Participant of any Award any rights or remedies thereunder. The exculpation and indemnification provisions of Section 3.5 will inure to the benefit of an Administrator’s estate and beneficiaries and legatees.
20.19Plan Headings. The headings in the Plan are for the purpose of convenience only and are not intended to define or limit the construction of the provisions hereof.
Linde plc | Appendix 3-22
Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY D53236-P55695-Z80062 ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! For Against Abstain ! ! ! ! ! ! 1c. Prof. DDr. Ann-Kristin Achleitner 1d. Prof. Dr. Clemens Börsig 1e. Dr. Nance K. Dicciani 1f. Dr. Thomas Enders 1k. Prof. Dr. Martin H. Richenhagen 1j. Dr. Victoria Ossadnik 1i. Larry D. McVay 1h. Edward G. Galante 1l. Robert L. Wood 1g. Franz Fehrenbach The Board of Directors recommends that you vote "FOR" PROPOSALS 2a and 2b, 3, 4, 5, 6, and 7. 3. To approve, on an advisory and non-binding basis, the compensation of Linde plc's Named Executive Officers, as disclosed in the 2021 Proxy Statement. 2b. To authorize the Board, acting through the Audit Committee, to determine PWC's remuneration. In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof. Please sign name exactly as it appears on this card. Joint owners should each sign. Attorneys, trustees, executors, administrators, custodians, guardians or corporate officers should give full title. 2a. To ratify, on an advisory and non-binding basis, the appointment of PricewaterhouseCoopers ("PWC") as the independent auditor. 4. To approve, on an advisory and non-binding basis, a Directors' Remuneration Policy for the Company's Directors as required under Irish law. 5. To approve, on an advisory and non-binding basis, the Directors' Remuneration Report for the financial year ended December 31, 2020 as required under Irish law. 6. To approve the 2021 Linde plc Long Term Incentive Plan. 7. To determine the price range at which the Company can re-allot shares that it acquires as treasury shares under Irish law. 1b. Stephen F. Angel 1a. Prof. Dr. Wolfgang Reitzle Nominees: LINDE PLC 1. Election of Directors. The Board of Directors recommends a vote "FOR" the nominees listed below. BY MARKING THIS CARD, YOU ARE VOTING ALL OF THE LINDE PLC ORDINARY SHARES HELD OF RECORD AND THOSE HELD IN THE SAVINGS PLAN(S). For Against Abstain LINDE PLC THE PRIESTLEY CENTRE 10 PRIESTLEY ROAD, SURREY RESEARCH PARK GUILDFORD, SURREY GU2 7XY UNITED KINGDOM ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! IF YOU WISH TO VOTE BY INTERNET OR TELEPHONE, PLEASE READ THE INSTRUCTIONS BELOW VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time on July 25, 2021. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/LIN2021 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time on July 25, 2021. Have your proxy card in hand when you call and then follow the instructions VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.
ANNUAL GENERAL MEETING OF SHAREHOLDERS — JULY 26, 2021 AT 1:00 P.M., IRISH TIME VIRTUAL MEETING FORMAT ACCESSIBLE AT www.virtualshareholdermeeting.com/LIN2021 AND AT THE OFFICES OF ARTHUR COX LLP, TEN EARLSFORT TERRACE, DUBLIN 2, D02 T380, IRELAND IF YOU PLAN TO ATTEND THE MEETING IN PERSON, PLEASE NOTE: * Only shareholders, and the invited guests of Linde plc, will be granted admission to the Annual General Meeting. * To assure admittance: – If you hold Linde plc ordinary shares through a broker, bank or other nominee, please bring a copy of your broker, bank or nominee statement evidencing your ownership of Linde plc ordinary shares as of 1:00 P.M., Irish Time on the July 24, 2021 voting record date – Please bring a photo ID, if you hold shares of record as of 1:00 P.M., Irish Time on July 24, 2021, including shares in certificate or book form or in the Linde plc Dividend Reinvestment and Stock Purchase Plan (“DRISP”) – Please bring your employee ID if you are an employee shareholder * The Annual General Meeting will start promptly at 1:00 P.M., Irish Time, on Monday, July 26, 2021. IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL GENERAL MEETING TO BE HELD ON JULY 26, 2021: THE PROXY STATEMENT, 2020 FORM 10-K AND ANNUAL REPORT TO SHAREHOLDERS AND 2020 IFRS ANNUAL REPORT ARE NOW AVAILABLE FOR VIEWING AND DOWNLOADING AT: 2021 Notice of Annual General Meeting and Proxy Statement: https://investors.linde.com/proxystatement 2020 Form 10-K and Annual Report to Shareholders: https://investors.linde.com/annualreport 2020 IFRS Annual Report: https://investors.linde.com/ifrsreport D53237-P55695-Z80062 PROXY/VOTING INSTRUCTION CARD This proxy is solicited on behalf of the Board of Directors of Linde plc for the Annual General Meeting of Shareholders on July 26, 2021 I (we) hereby authorize Matthew J. White and Guillermo Bichara, or either of them, and each with the power to appoint his substitute, to vote as Proxy for me (us) at the Annual General Meeting of Shareholders of Linde plc to be held by: (a) a VIRTUAL meeting format accessible at www.virtualshareholdermeeting.com/LIN2021; and (b) through an in-person meeting, as required by Irish law, at the offices of Arthur Cox LLP, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland, on July 26, 2021 at 1:00 P.M., Irish Time, or any adjournment or postponement thereof, the number of ordinary shares of Linde plc which I (we) would be entitled to vote if personally present. The proxies shall vote such shares as directed on the reverse side of this card and the proxies are authorized to vote in their discretion upon such other business as may properly come before the Annual General Meeting and any adjournments or postponements thereof. I (we) revoke all proxies heretofore given to vote at the Annual General Meeting. Please see the notice in the 2021 Linde plc Proxy Statement regarding possible changes to the in-person meeting in Ireland as a result of the COVID-19 pandemic. If I (we) properly sign and return this proxy card, the shares will be voted as I (we) specify on each Proposal. If I (we) do not specify a choice on one or more Proposals, the proxies will vote the shares as the Board of Directors recommends on each such Proposal. For Participants in the Linde Retirement Savings Plan and the Savings Program for Employees of Praxair Puerto Rico BV and its Participating Subsidiary Companies: As to those Linde plc ordinary shares, if any, that are held for me in the aforementioned Savings Plans, I instruct the Trustee of the applicable Savings Plan to vote my shares as I have directed on the reverse side of this proxy card. Where I do not specify a choice, the shares will be voted in the same proportion as the trustee votes the shares for which it receives instructions. THIS PROXY CARD IS ONLY VALID WHEN SIGNED AND DATED. (Continued, and to be marked, dated and signed, on the other side)